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ABSTRACT 
 
 
Antiretroviral medication has improved HIV-related prognosis. Yet HIV-associated 
neurocognitive disorders (HAND) have substantially increased, leading to 
decreased quality of life, increased illness severity and mortality. In the research 
literature, executive dysfunction (e.g. planning difficulties and cognitive 
inflexibility) has been identified as prominent in HAND, but there has been little 
analysis of the componential and qualitative aspects underpinning these deficits. 
Targeted and theory-driven neurorehabilition for HAND is limited due to the lack 
of this type of detailed information. This study aimed to explore whether 
induction, a key aspect of executive function, is impaired in HAND, and if so, the 
underpinning processes causing impairment. 
 
Thirteen participants with HAND and thirteen HIV-negative participants were 
matched for gender, age, education and reading ability. The HAND population 
were assessed for current functioning, and compared to the control group on 
verbal and non-verbal tests of induction. Qualitative analysis was used to derive a 
componential scoring system for the Brixton Spatial Anticipation Test (non-verbal 
measure of induction) to qualitatively and quantitatively characterise performance 
in the HAND group compared to the non-clinical sample.  
 
Results suggest that induction is impaired in HAND. However, initial rule 
detection appears spared. Processes such as slowed information processing, 
and lapses in attention and working memory affected induction across the HAND 
group. Other deficits appeared idiosyncratically: accordingly, no single profile of 
impairment was identified. This study showed that taking simple measures of 
executive function at face value does not provide an accurate description of 
individual performance in HAND. The results are interpreted in the context of a 
need for componential analyses of neuropsychological tests, generally in 
research and when interpreting scores in practice. 
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1 INTRODUCTION 
 
 
1.1  Literature search 
 
A systematic literature search was conducted (August 2014 to May 2015) using 
EBSCO, PubMed, Science Direct and Scopus. Terms used were ‘HIV’, ‘HIV-
associated neurocognitive disorders’, ‘cognitive impairment’, ‘executive function’, 
‘concept formation’, ‘abstraction’ and ‘induction’. No time period was set. The 
reference list of each relevant article was examined to identify literature missed 
during the search.  
 
 
1.2  HIV – History 
 
Human immunodeficiency virus (HIV) is a highly infectious disease that came to 
the attention of medicine in the form of acquired immune deficiency syndrome 
(AIDS) in the early 1980s. From this time the disease has spread, quickly 
infecting almost 78 million people, killing an estimated 39 million of that number 
(UNAIDS, 2013). The history of HIV is associated with the politics of contagion 
and the influence of beliefs regarding moral behaviour on medicine, treatment 
and prevalence. The scope of which is too large to document here, therefore a 
brief summary will be presented. 
 
 
1.2.1 The beginning of the pandemic 
In 1981 an increasing number of previously healthy men in the United States of 
America (USA) contracted and quickly died from similar, treatment resistant 
opportunistic infections and cancers such as aggressive Kaposi’s sarcoma 
(Hymes et al., 1981) and Pneumocystis Carinii pneumonia (Friedman-Kien et al., 
1981). The common factor amongst these men was their sexuality, leading 
medical professions to erroneously attribute the cause of death to a contagion 
only affecting men who had sex with men, naming it among other things, gay-
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related immunodeficiency disease. Six months later intravenous drug users and 
haemophiliacs were also affected, shifting the understanding of the disease, and 
the name to AIDS (Centers for Disease Control, 1982). In 1983 two different 
research groups (Gallo et al., 1983; Barré-Sinoussi et al., 1983) purported to 
have discovered the causal substrate of AIDS. Following verification that these 
two findings described the same factor, HIV was named. 
  
HIV exists in two forms; HIV-1 and HIV-2 (Kumar & Clark, 2012). They have 40% 
structural similarity but HIV-1 poses a greater threat, particularly HIV-1 group M, 
accounting for 90% of all infections to date (Taylor, Sobieszczyk, McCutchan & 
Hammer, 2008). HIV, irrespective of strain, is a lentivirus (a slow virus which 
takes time to exert its adverse effects on the host) meaning initial infection occurs 
without symptomatology. It was this delay that made identification of the link 
between HIV and AIDS so difficult in early research. 
  
  
1.3 Transmission of the virus to humans 
 
It is now generally accepted that HIV originated in non-human primates in sub-
Saharan Africa in the form of Simian Immunodeficiency Virus (SIV). For example, 
HIV-1M links to the SIV carried by a subspecies of chimpanzees of south eastern 
Cameroon. SIV has been present for over 32,000 years (Sharp & Hahn, 2011) 
and is non-pathogenic to the primate host. In the late 19th or early 20th century 
SIV passed across the species barrier through zoonosis (WHO, 2007) mutating 
to HIV.  
 
Hunter theory is the predominant explanation for cross-species transmission. It 
proposes that zoonosis occurred as early as the 1930s through bushmeat 
activities, contact with infected animal blood and excretions during hunting and 
meat eating. Serial passage theory (Marx, Drucker & Schneider, 2011) and 
colonial rule are thought to have escalated transmission to pandemic status. For 
example, colonialism led to labour camps and lowered immune systems making 
people more susceptible to any virus, lack of food meant animal meat made up 
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for scarce resources, and multiple needle use for medication and prostitution 
(provided to ‘keep the workers happy’) led to increased transmission (Timberg & 
Halperin, 2012; Giles-Vernick et al., 2013 ). 
  
Other theories including the oral polio vaccine theory (which suggested that the 
live vaccine was created in infected primates leading to transmission during polio 
inoculation; Hooper, 1999) and conspiracy theory (suggesting HIV was created in 
a lab and designed as a weapon of genocide; Horowitz, 1997) have been 
considered but little evidence supports either approach (e.g. Sharp & Hahn, 
2010). 
  
Perhaps the most controversial theory to date is the Duesberg hypothesis 
(Duesberg & Rasnick, 1998) and AIDS Denialism Movement.  The movement 
believes that HIV is a harmless passenger virus to the ‘real’ non-infectious cause 
of AIDS, which purportedly includes pharmaceutical and recreational drug use. 
Between 2000 and 2006, Thabo Mbeki, President of South Africa at that time, 
believing the Duesberg hypothesis rejected anti-retroviral medication in favour of 
garlic and other natural remedies leading to the deaths of up to 365,000 people 
(Chigwedere, Seage, Gruskin, Lee & Essex, 2008). Scientific evidence plus this 
loss of life has discredited this hypothesis. 
  
  
1.4  HIV - Present day 
 
1.4.1 Epidemiology 
In 2013 the number of people living with HIV (referred to as PLWH from this point 
forward) globally was estimated at 34 million (UNAIDS, 2013), with 107,800 (95% 
confidence interval: 101,600 – 115,800) of those living within the United Kingdom 
(UK; Public Health England, 2014). Prevalence has decreased over the last 
decade thanks to initiatives including the Joint United Nations Programme on 
HIV/AIDS. In the UK diagnosis of new cases decreased from an estimated 8,000 
per year between 1995 and 2005 (Health Protection Agency, 2012), to 6,000 per 
year in 2013 (Public Health England, 2014). While numbers are decreasing, the 
global burden of HIV remains high. 
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Epidemiological estimates must be interpreted with caution due to their inherent 
imprecision. This is further complicated in the case of HIV as many people live 
with the infection without being aware of their positive status; 24% of those 
estimated to be living with HIV in the UK in 2013 fell into this category (Public 
Health England, 2014). 
 
 
1.4.2  Transmission 
HIV is passed between individuals when infected bodily fluids (e.g. blood, semen 
and breast milk) make contact with the bloodstream, delicate mucous membrane, 
or skin lesion of an HIV-negative individual. Blood transfusion has the highest 
‘per-act’ risk of HIV transmission, followed by mother-to-child transmission (Patel 
et al., 2014). Globally however, transmission is predominantly through 
intercourse (Kumar & Clark, 2012). The mucosal lining of the anus is more liable 
to tear than the vagina, making anal sex more risky in terms of transmission 
(Patel et al., 2014). This is reflected in the 2013 UK data, which reported that 
54% of new cases were linked to men having sex with men and 45% to 
heterosexual sex (vaginal and anal sex). Only 1% of new cases linked to other 
routes of transmission including intravenous drug use, mother-to child 
transmission and exposure to contaminated blood products outside of the UK 
(Public Health England, 2014). Condoms, dental dams, needle exchanges, and in 
utero and postpartum antiretroviral medications have been shown to prevent 
transmission.  
 
Transmission processes that include sex and drug use have led to stigma and 
discourses around HIV, including suggestions that those who contract it are in 
some way at fault and deserving of the disease, due to what is seen as morally 
questionable lifestyle choices and promiscuity. Research into the continuing 
spread of HIV implicates this kind of stigma and subsequent policy making, or 
lack of (e.g. Pisani, 2008). 
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Norman Fowler (2014), the medical health secretary in the UK at the time of the 
AIDS outbreak has addressed this topic specifically blaming continued 
transmission on the intolerance and prejudice of politicians, the media and 
society. For example, Russia and the USA do not use needle exchange 
programmes despite strong evidence of their effectiveness in preventing 
transmission. Furthermore, evidence suggests sex workers, who make up a large 
percentage of individuals vulnerable to HIV transmission, respond well to HIV 
prevention campaigns including distribution of free condoms and education 
around the necessities of their use. However, the USA will not fund such 
programmes and in some areas, including Los Angeles, possession of condoms 
counts as evidence of sex work. Additionally, stigma of HIV decreases likelihood 
of testing, and disclosure of an HIV-positive status, all of which increase risk of 
transmission.  
 
 
1.4.3 Natural history of HIV 
The natural progression of HIV post-infection is described as following three 
stages, unless interrupted by medical intervention (WHO, 2007): 
  
1. Acute Response to HIV infection 
Two to four weeks post-infection, extreme flu-like symptoms occur in 40-90% of 
individuals. At this stage blood tests do not detect HIV due to a lack of traceable 
antibodies in bodily fluids (95% of people ‘seroconvert’ within the first six months; 
WHO, 2004). Misdiagnoses are therefore often made, such as malaria.  
  
Once in the body the virus replicates quickly and host CD4 counts start to 
decrease. At this time viral load in the blood and other bodily fluids can reach 
more than 1 million copies per millimetre. As a direct logarithmic relationship 
exists between viral load and transmission likelihood (Maartens, Celum & Lewin, 
2014), this phase is a significant contributor to the spread of HIV as the individual 
is often unaware of their new status and therefore not exercising anti-
transmission precautions 
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2. Asymptomatic HIV infection/clinical latency 
Following the acute phase, host antibodies respond to the virus leading to slowed 
viral replication and an asymptomatic phase, which can last for a long period 
(WHO, 2004). Numbers of CD4 cells recover in this phase, however, the virus 
remains active within the lymph nodes. 
 
Antiretroviral medication introduced at this time has been shown to improve 
survival rate. If untreated, the viral load will eventually increase again and the 
disease will progress. 
 
3. HIV disease and AIDS 
Once the CD4 cell count drops below 200 cells per cubic millimetre of blood, cell 
mediated immunity is lost and an individual is considered to have HIV disease or 
AIDS. Opportunistic infections (e.g. tuberculosis) and tumours (e.g. Kaposi’s 
sarcoma) occur in this phase and can be fatal if untreated (McArthur, Steiner, 
Sacktor & Nath, 2010). 
  
Increasing evidence suggests that HIV also attacks the central nervous system 
(CNS) leading to HIV-associated neurocognitive disorders (HAND), however the 
specific stage within which this occurs is unknown.  
 
 
1.4.4 Pathology linked to natural history 
Once inside the body HIV replicates and targets cells expressing the CD4 
receptor and chemokine receptors, CCR5 and CXCR4; that is, cells responsible 
for cell-mediated immunity, particularly the CD 4+ T-lymphocyte cells (called CD4 
cells from this point on) and monocytes and macrophages (CD 68+). CD4 cell 
depletion has been linked to complex mechanisms including non-inflammatory 
(e.g. activation of caspase 3, triggering apoptosis of infected and activated cells) 
and inflammatory processes (e.g. activation of caspase 1, leading to pyroptosis of 
non-productively infected bystander cells; Doitsh et al., 2014). Inflammatory 
mechanisms perpetuate further inflammation potentially accounting for a large 
proportion of lost T-cells. Following this the body produces antibodies, partially 
suppressing the virus. The virus then mutates, inhibiting the antibodies ability to 
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rid the body of HIV. This explains the asymptomatic latent phase. If un-
medicated, viral load increases and the carrier progresses towards AIDS. Overall 
this suggests that the immune system takes centre stage in this disease, acting 
as a protective and pathogenic mechanism (Hong & Banks, 2015). 
 
The existence of infected persons who are ‘elite controllers’ (those whose CD4 
levels remain high irrespective of HIV infection and lack of medication) 
challenges the notion that HIV has a determined natural progression. 
 
 
1.4.5 Treatment 
Until recently HIV was seen as a ‘death sentence’. The first antiretroviral 
medications (developed in 1987) improved short-term prognosis but did not 
suppress viral mutation, leading to drug-resistant strains of the infection and 
limited long-term benefits (Ellis, Langford & Masliah, 2007). Subsequently, 
combination antiretroviral therapy (cART) was developed in 1996, creating the 
current gold standard of HIV management. Good adherence to cART is said to 
be effective in up to 70% of patients, decreasing viral load to undetectable levels 
allowing for recovery of CD4 cells and expectation of near normal life expectancy. 
Now over 75% of people over 50 living with HIV die of non-HIV related causes 
(Braithwaite et al., 2005). 
 
During treatment low level latent infection resides in resting CD4 cells meaning 
disruption to medication causes re-emergence, proliferation and mutation of the 
virus leading to illness and drug resistance, only treatable with an alternative drug 
(Dahabieh, Battivelli & Verdin, 2015). As a result, medication regimens must be 
adhered to for life. Barriers to adherence include rare but significant side effects 
such as peripheral neuropathy, liver toxicity, lipodystrophy syndromes (Lucas & 
Nelson, 2015) and in rare cases death (Abers, Shandera & Kass, 2014). 
 
The hunt for a ‘cure’ is ongoing, with scientists exploring the possibility of a 
functional (removing the negative effects of the virus, and detectable load from 
the blood) or sterilising cure (ridding the body of the virus in its entirety). Only one 
person has currently achieved sustained sterilisation, the ‘Berlin Patient’ (Hütter 
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et al., 2009). However the complex and high risk factors involved in his treatment, 
which included a CCR5-negative bone marrow transplant for leukaemia, have 
made this a difficult scenario to recreate (Cockerham & Hatano, 2014). 
 
  
Future treatment may include gene therapy that creates HIV-resistant cells within 
the carrier. At present, gene therapy using modified human stem cells has proved 
efficacious within animal models (e.g. Bird, 2014; Barclay et al., 2014) and further 
work is being carried out to determine whether long term suppression or 
sterilisation of the virus can be achieved within humans. 
  
  
1.4.6 HIV since cART 
The advent of cART improved mortality rates. Yet it also altered the 
neurocognitive profile and incidence of HAND. 
 
 
1.5  HAND 
 
Prior to cART, severe cognitive impairment known as HIV-associated dementia 
(HAD), was noted in up to 15% (Underwood, Robertson & Winston, 2015) to 20% 
(Brew, 2001) of AIDS-defining illnesses (percentages depend on data source). 
These impairments were considered to be due to immunosuppression and 
opportunistic infection (e.g. toxoplasmosis), progressive multifocal 
leukoencephalopathy (PML), or structural neurologic disorders (e.g. brain 
tumours or strokes). 
  
Since cART administration, HAD cases have decreased to approximately 1% 
(Heaton et al., 2011). However, mild to moderate neurocognitive disorders have 
increased and are being diagnosed in up to 50% of HIV-positive individuals 
(Robertson et al., 2007). As viral load and opportunistic infections are low in 
medicated persons, this suggests that HIV itself causes neurological impairment. 
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1.5.1 HAND Terminology 
AIDS dementia complex (ADC; Navia, Jordan & Price, 1986) was the first term 
used to describe the cluster of neurocognitive symptoms (behavioural change, 
motor dysfunction and cognitive impairment) noted in some cases of AIDS-
defining illness. The validity of ADC as a distinct syndrome was questioned 
(Catlan & Burgess, 1996), as was the dichotomous nature of the diagnosis, which 
potentially led those with mild cognitive impairment, and significant impairments, 
to become clustered within the same ‘dementia’ group. 
  
To manage critiques, the American Academy of Neurology AIDS Task Force 
devised a classification system with two categories; HIV-associated dementia to 
represent those with more profound motor, behavioural and psychosocial deficits, 
and minor cognitive motor disorder for those less severely impaired. A further 
category, sub-syndromic neuropsychological impairment, was added in 1995 to 
categorise mild impairment without functional impact on activities of daily living 
(ADLs; Grant & Atkinson, 1995). Again, lack of specificity and inconsistent use of 
the categories (Griffin & Gerhardstein, 2010) led to criticism and subsequent 
revisions. 
  
The current western diagnostic system of HAND is set out in the Frascati criteria 
(Antinori et al., 2007). Devised by the National Institutes of Health, the framework 
attempts to capture a spectrum of neurologic disease including the functional 
impact of impairment, range and complexity of presentations, available 
neuropsychological assessment and treatment protocols, as well as the effect of 
co-morbid conditions (Griffin & Gerhardstein, 2010). The framework’s HAND 
subcategories are: 
  
1. Asymptomatic Neurocognitive Impairment 
30% of PLWH are thought to meet criteria for asymptomatic neurocognitive 
impairment (ANI), which describes mild neurocognitive impairment on 
standardised tests without significant impact on everyday functioning. Absence of 
functional impairment suggests that most would be unaware of any cognitive 
change. (McArthur et al., 2010). 
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The CNS HIV Anti-Retroviral Therapy Effects Research (CHARTER) study, which 
monitored neurocognitive change in a cohort of 347 HIV-positive participants over 
35 months via biannual neuropsychological assessment, found that ANI 
presented a two to six fold increased risk of progression to mild neurocognitive 
disorder (Grant et al., 2014). Subsequently it has been suggested that HIV-
positive individuals be screened for ANI in order to tailor treatment appropriately 
and halt further progression. At this point, no treatment exists that would deter 
this progression as underpinning mechanisms of HAND remain unclear.   
 
2. Mild Neurocognitive Disorder 
20-30% of PLWH are thought to meet criteria for mild neurocognitive disorder 
(MND; Sacktor, 2002), which describes mild to moderate neurocognitive 
impairment (at least one standard deviation below normative data matched for 
age and education) in two or more domains plus change in daily functioning. 
MND is linked to reduced medication adherence, subsequent increased risk of 
cART resistance and mortality (McArthur et al., 2010). 
  
3. HIV-associated Dementia 
1% (Heaton et al., 2011) to 5% (McArthur, 2004) of PLWH are thought to meet 
criteria for HAD, which describes moderate to severe neurocognitive impairment 
(two standard deviations below normative data matched for age and education) in 
two or more domains plus marked functional impairment not explained by 
comorbidity or delirium. HAD is linked to increased mortality (Woods et al., 2009). 
 
 
1.5.2 Critiques of the Frascati Criteria, diagnosis and HAND 
The Frascati criteria and HAND are not without criticism. For example, functional 
impairment often depends on self-report measures. These can elicit false-
positives and negatives due to exaggerated self-criticism and lack of insight 
(Heaton et al., 2010). Assessment of cognition is based on short screening 
measures or neuropsychological assessments, which have additional problems 
such as inappropriately matched normative data. Consequently, it has been 
suggested that clinical use of the Frascati criteria could lead to misdiagnosis in 
approximately 14% of PLWH (Nightingale et al., 2014). 
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Misdiagnoses have implications for costs of care, treatment regimen (as 
antiretroviral medication may be modified upon diagnosis of HAND), and anxiety 
and stigma for those misdiagnosed. This is of note as multiple groups including 
the Mind Exchange Working Group (2013) and The British HIV Association 
(2012) advocate for population wide screening of PLWH for HAND. This request 
seems understandable considering the link between ANI and MND, and HAND 
and life threatening complications. However, misdiagnosis and the lack of an 
available medicine that reliably prevents progression of ANI to MND makes the 
benefits of population wide screening debatable. 
  
Repeated assessment suggests that cognition in PLWH generally fluctuates over 
time, and in both directions, i.e. improved functioning has been seen as often as 
deterioration (McArthur, 2004). Fluctuations in cognition may reflect instability in 
disease processes and viral replication, or limitations in the neuropsychological 
assessments measuring ability (Nightingale et al., 2014). The Frascati criteria do 
not reflect these changes, suggesting further concern for the classification system 
and misdiagnoses.  
 
These arguments reflect criticisms levelled at the construction of diseases more 
widely. For example, Sontag (1991) discussed the necessity of deconstruction of 
mainstream discourses, which increase the suffering of the individual more than 
the disease process causing it. For example, she stated that labelling an 
individual as HIV-positive but asymptomatic was the same as saying someone 
was ill (but not yet aware) and awaiting death, without actual evidence that the 
definitive ending of all HIV cases was AIDS. Furthermore, she proposed that an 
HIV diagnosis itself created a stigma and fear that could contribute to cognitive or 
behavioural changes without actual pathology. Sontag wrote about HIV and not 
HAND. However, ANI maps closely onto her discussions, as evidence suggests it 
increases risk of further impairment without proof that this will happen to 
everyone. Diagnosis of ANI therefore suggests problems that may not yet be 
there but are ‘sure’ to come. The stigma and fear of diagnosis could cause 
changes subsequently misattributed to mild cognitive impairment.  
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Irrespective of specific diagnostic label or classification system, HAND has been 
linked to decreased quality of life, employment rate, life expectancy (Tozzi et al., 
2007) and functional ability (Garvey, Yerrakalva, & Winston, 2009). At present no 
alternative for the criteria has been presented and therefore, bearing these 
criticisms in mind, this research worked with the notion of HAND based on this 
framework.  
 
 
1.5.3 Neuropathology 
The neuropathological mechanisms of HAND outlined here refer to primary (i.e. 
the direct effect of HIV on the CNS) and not secondary pathologies (i.e. 
opportunistic infections which further affect the CNS, including PML and 
lymphoma). 
 
The process between initial HIV-1 infection and HAND starts when HIV-1 passes 
through the blood brain barrier (BBB) as either cell-free virus or within infected T-
cells and monocytes (Hong & Banks, 2015). Inside the CNS the virus produces 
cytokines and other neurotoxic responses, destabilising the BBB allowing the 
virus to cross more freely (Hong & Banks, 2015). Cell death then ensues through 
infection of previously uninfected cells and production of proinflammatory 
cytokines including TNF and IL-1ß from infected monocytes and T-cells which 
activate further microglia, astrocytes, perivascular macrophages (cells tasked 
with initiating immune responses within the body when threat is encountered to 
protect it from further injury). Neurotoxic factors are then released, including 
inflammatory mediators and excitatory amino acids, disrupting neuronal function 
and leading to cell death. Cytokines in the blood, outside of the BBB may also act 
on CNS cells, further increasing inflammation and cell depletion (Hong & Banks, 
2015). 
  
HIV lacks specificity in terms of the neuronal forms it affects, unlike other kinds of 
neurodegeneration (e.g. Parkinson’s targets nigrostriatal dopaminergic neurons). 
Instead diffuse damage occurs. However, pathogenic processes principally affect 
the basal ganglia, frontal cortex, hippocampus and white matter tract 
connections; preferentially affecting the fronto-striato-thalamo-cortical loops 
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(Thompson et al., 2005; Ellis et al., 2007). Neuroimaging, including structural 
Magnetic Resonance Imaging (sMRI) and diffusion tensor imaging, supports this 
explanation finding that subcortical brain regions are primarily affected, until later 
in the disease process when cortical areas may also be compromised (Lentz et 
al., 2009). Neurocognitive change and HAND also include ventricular 
enlargement, cerebral atrophy (Ances & Ellis, 2007), hypodensities and 
decreased diffusivity in white matter structures including frontal white matter and 
the corpus callosum (Leite et al., 2013), altered deep grey matter and subcortical 
regions (Valcour, Sithinamsuwan, Letendre & Ances, 2011). 
 
 
1.5.4 Mechanisms of HAND in the cART era 
HAND has increased despite cART’s ability to decrease viral load to near 
undetectable levels (which would suggest the neuropathological mechanisms 
outlined above could not occur). Determining the mechanism through which 
HAND continues to occur is critical if it is to be attenuated. A direct mechanism of 
cART leading to HAND is unlikely to be found as not all PLWH receive this 
diagnosis. Also, in some cases length of time on cART is linked to improved 
learning and information processing speed (Giesbrecht et al., 2014). Mechanisms 
are therefore likely to be complex, as on one hand cART has increased 
problems, yet on the other it has helped cognition. The main theories proposed to 
date link to: 
  
1. Irreversible pre-therapy damage to the CNS 
HIV may create structural and functional changes prior to cART administration 
not ameliorated by medication, leading to cognitive impairment. For example, the 
nadir CD4 count (a measure of immunosuppression and cellular depletion prior to 
medication) is considered to be a useful measure to predict cognitive change 
(Ellis et al., 2011). 
  
2. Persistence of HIV-related pathological processes  
Pathological processes such as viral replication may continue in cART. For 
example, some ARTs do not cross the BBB suggesting the CNS (and 
cerebrospinal fluid if viral escape occurs; Hong & Banks, 2015) acts as a 
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reservoir for the virus, a place where ongoing damage can occur without 
suppression. The CNS therefore has longer exposure to HIV than before, which 
as the cohort of PLWH ages will only increase. 
  
Research addressing this hypothesis has examined the efficacy of ART with high 
(compared to low) CNS penetration. The findings are patchy with some studies 
showing high CNS penetration gave increased benefit and protection from HIV 
(e.g. Vassallo et al., 2014), and others showing no benefit (e.g. Ellis et al., 2014), 
or increased neurotoxicity and risk of HAD (e.g. Caniglia et al., 2014). 
  
The CNS immune response (started pre- or post-ART) to HIV is another process 
that may not be mediated by medication. Therefore inflammatory activity initiated 
to protect the body may become chronic (Gill & Kolson, 2014) causing vascular 
degeneration and CNS tissue damage (Heaton et al., 2011). 
 
3. ART neurotoxicity 
Some laboratory research suggests that ART may be neurotoxic and disrupts 
mitochondrial functioning (López-Armada et al., 2013). This indicates the 
medication itself may be damaging, leading to the kind of chronic inflammation 
seen in other neurodegenerative diseases (Underwood et al., 2015). However, to 
date, differentiating the effects of ART from other variables within clinical studies 
has been difficult. 
 
 
1.5.5 Neuropsychological profile of HAND 
Neurodegenerative HIV-related processes, while diffuse, link to specific profiles 
of cognitive impairment, which have changed since cART. 
  
Pre-cART impairment was linked to slowed motor and information processing 
speeds. Now HAND also encompasses deficits in learning, memory and 
executive functioning (Heaton et al., 2011). Early stages are categorised by 
changes in motor functioning, speed and attention. As these areas decline 
further, difficulties with fine motor control, gait, short-term memory and mental 
slowing occur (Grant, 2008; Nath et al., 2008). Visuospatial functions appear to 
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remain relatively intact (Heaton et al 1995). However, only seven to ten percent 
of people with HAND are thought to present without additional comorbidities 
(Heaton et al., 2011), such as stroke or PML. Therefore, presentations may vary. 
 
In response to known phenotypes, assessment for HAND covers domains 
including attention, information processing, motor skills, working memory, 
executive functions, language and memory (Cherner et al., 2007). 
 
 
1.5.6 Assessment tools 
As mentioned, there has been a drive to detect neurocognitive deficits in the early 
stages. Previously available brief screening tools have therefore been recruited 
and adapted to increase specificity for HIV-associated changes. For example, the 
Mini Mental State Examination (Folstein & Folstein, 1975), used as a screening 
tool for other types of cortical dementia (e.g. Alzheimer’s), has been shown to 
lack sensitivity for HAND. Insensitivity may be due to lack of questions assessing 
subcortical regions linked to HIV damage, such as the prefrontal-striatal 
connections responsible for executive functions, working memory and information 
processing.  
 
The HIV Dementia Scale was devised to assess subcortical functions, showing 
improved sensitivity and specificity when compared to similar brief measures 
(Power, Selnes, Grim & McArthur, 1995). Other specific measures, including the 
International HIV Dementia Scale (Sacktor et al., 2005) were devised, however 
they often lack sensitivity for mild impairment. The Montreal Cognitive 
Assessment, a generic measure for mild impairment has been shown to have 
good face validity for HAND sensitivity and highlights those needing further 
comprehensive assessment. However specificity and sensitivity of the tool varies 
across the literature (e.g. Brouillette et al., 2014; Janssen, Bosch, Koopmans & 
Kessels, 2015). 
  
Neuropsychological assessment is used for multiple purposes including: creating 
a profile of cognitive difficulties; identifying cognitive strengths, weaknesses and 
subsequent appropriate support plans that build on skills to improve or maintain 
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day to day functioning; monitoring cognitive functioning over time possibly in line 
with disease progression and medication regimens; informing decision-making 
about care plan appropriateness, for example determining whether an individual 
can manage complex medication regimens (Grant, 2008; Woods et al., 2009). 
Therefore comprehensive neuropsychological batteries provide more in-depth 
profiles of individual performance than any brief diagnostic tool, subsequently 
improving sensitivity and specificity.  
 
Problematically, neuropsychological assessment comprises multiple batteries 
and combinations of tests, rendering the available literature on HAND difficult to 
generalise as each paper utilises a different strategy. Furthermore, 
neuropsychological tests advertised as measuring specific domains (e.g. 
attention, information processing, working memory) require intact functioning of 
other domains. Therefore no test is completely ‘pure’, necessitating careful 
interpretation of results. 
 
 
1.5.7 HAND and contributing factors 
Multiple factors are suggested to influence the likelihood and severity of HAND. 
Much like research into other areas of HIV, findings are mixed. Pertinently, 
evidence documented thus far indicates HIV causes HAND in a percentage of 
cases. However, two recent investigations found that when demographic 
variables (including gender, age, schooling, co-morbidities) were controlled for, 
cognition did not differ significantly between HIV-positive and HIV-negative 
women (Manly et al., 2011), or men who have sex with men (McDonnell et al., 
2014). From these cases, it was suggested that HIV-related decline might be 
overestimated when patient sample performance is compared to ill-matched 
normative data. These findings have not yet generalised to other studies. This 
does not invalidate their findings but may suggest other research has not had 
tight control over demographic factors. This needs to be considered when 
interpreting the following literature. 
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Gender 
Until the late 1990’s PLWH were mainly men. However, the millennium saw 
women become the fastest growing HIV population (Cohn, 2003). Current global 
distribution of HIV is shared almost equally between men and women, dependent 
on geographical location. For example, women make up approximately 57% of all 
PLWH in sub-Saharan Africa (UNAIDS, 2013), and only 32% of PLWH in the UK 
(Public Health England, 2014). 
  
Due to the previous global and current local (western countries) 
overrepresentation of men, the majority of research carried out to date on HIV 
and its neurological sequelae has excluded women. Therefore biased data and 
norms may have been incorrectly generalised to both sexes (Faílde‐Garrido, 
Alvarez & Simón‐López, 2008). As a result, a small but growing literature has 
looked into gender differences in HIV and cognition with mixed outcomes. 
  
Suggestions of a gender bias in HIV-related cognition have gone full circle over 
the last two decades. Early epidemiological studies suggested that women were 
more vulnerable to HAND, particularly in the pre-cART era, with more than 
double the number of cases of ADC diagnosed in women than men (Chiesi et al., 
1996). Following cART, comparable rates were noted across genders in the USA 
(Robertson et al., 2004), Puerto Rico, Europe and Australia (Wojna et al., 2006). 
However, the recent CHARTER study (Heaton et al., 2010) found that women 
were up to three times more likely to experience deleterious effects of HIV (Albert 
& Martin, 2014). 
  
Explanation for the discrepancy noted between genders, when noted at all, has 
been linked to biological aspects (such as difference in hormone levels, brain 
structure, body composition; Faílde‐Garrido et al., 2008), increased intravenous 
drug use (Lopez, Wess, Sanchez, Dew & Becker, 1999) and mental health 
problems in women (Basso & Bornstein, 2000). More commonly however, it has 
been related to socio-political aspects of gender, such as the lower social status 
of women and their decreased access to education (e.g. Lopez et al., 1999; Maki 
& Martin-Thormeyer, 2009; Heaton et al., 2010) and protective services. For 
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example, differences in HAND prevalence across genders in Zambia were 
explained by sex-related social, financial and healthcare disadvantages affecting 
women’s education, treatment availability and adherence (Hestad et al., 2012). 
  
Aside from prevalence, little research has investigated the neuropsychological 
profile of HAND across genders. The limited research available suggests no 
significant difference in profiles. Outliers to this finding includes one study 
showing differences in verbal learning, delayed recall and working memory when 
HIV-positive men were compared to women matched for variables including 
disease stage (Maki et al., 2009). Another indicated a trend towards females 
experiencing higher rates of impairment (51.9% of males and 54.8% of females) 
than men particularly in psychomotor speed, attention and verbal memory, while 
men experienced more difficulty in visual memory, attention and abstract 
reasoning. 
  
Age 
In the next two decades, the majority of PLWH will be over 50 (Winston & 
Underwood, 2015). This is of particular concern as normal ageing processes lead 
to immunovirological deregulation (increased susceptibility to, and decreased 
ability to fight infection; Gardner, 1980), neural damage (Ernst & Chang, 2004), 
general comorbidities (e.g. cardiovascular disease) and mortality (Önen et al., 
2010). Furthermore HIV is associated with accelerated ageing, with functional 
MRI finding blood oxygen level dependent responses in young HIV-positive 
individuals mirroring those found in HIV-negative individuals that are 15-20 years 
older (Ances et al., 2010). Therefore, accelerated decline and potentially 
synergistic effects of pathological processes may be expected. 
  
It is unsurprising therefore that risk of HAND increases with age. With older 
adults at three-fold risk of HAND compared to young PLWH (Cherner et al., 2004; 
Valcour et al., 2004). Illustrating this, it was found that older PLWH had increased 
deficits in episodic (Sacktor et al., 2007) and prospective memory (Woods, 
Dawson, Weber, Grant & HIV Neurobehavioural Research Center Group, 2010), 
and executive functions including cognitive flexibility (Iudicello, Woods, Deutsch, 
Grant & HIV Neurobehavioral Research Program Group, 2012) than younger 
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PLWH. These age and HIV-related declines have been linked to disruption of 
ADLs, medication adherence (Hinkin et al., 2004), health-related quality of life 
(Doyle et al., 2012) and lower mood (Shimizu et al., 2011).  
  
Education and cognitive reserve 
Higher education level has been negatively correlated with onset of HAND 
(Heaton et al., 2015). This could suggest that education protects against HAND. 
Cognitive performance is generally improved by increased years of education as 
neuropsychological testing directly maps onto western educational procedures. 
Therefore, it is important not to conflate lower achievement in testing with a 
HAND diagnosis in those with lower educational experience, as this may be the 
influencing factor rather than HIV. Quality of education (purported to be 
measured by reading tests) is reported to be a more accurate measure of the 
exposure an individual had to learning than years of education, as teaching 
quality offered across the globe varies (Manly, Jacobs, Touraji, Small & Stern, 
2002). 
  
One explanation of education’s protective ability is the cognitive reserve model 
(Stern, 2013). This states that higher reserve (quantified as prolonged education, 
higher IQ, reading skills and level of occupation) increases resilience to brain 
pathology through efficient pre-existing cognitive processes or ability to deploy 
alternative pathways. In short, it is thought that increased education leads to 
more complex, adaptable and available neural networks. This model suggests 
there will be a critical threshold of pathology past which functional impairment 
cannot be attenuated. The concept of cognitive reserve has been utilised in 
studies of HIV as many have linked higher reserve to improved outcomes 
(Heaton et al., 2015) and successful ageing (Heaton et al., 2015; Malaspina et 
al., 2011), and lower reserve to symptomatic HAND (Morgan et al., 2012). 
 
Few have critiqued the notion of cognitive reserve within the neuropsychological 
literature. However, it is possible that the data upon which reserve models are 
based do not reveal a protective factor, but instead reflect the fact that people 
who perform well on neuropsychological measures pre-brain pathology, have 
further to fall to reach the impaired range. 
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Culture and Ethnicity 
Lack of access to precautions and treatment has meant the majority of PLWH are 
found in sub-Saharan Africa. Despite this, most HAND-related research is carried 
out in western cultures making it difficult to understand the link between cultural 
variables and HAND. Furthermore, test resources that are culturally appropriate 
(i.e. that are in the relevant language, use culturally normative items and data) 
are limited in international settings such as in sub-Saharan Africa (Robertson, 
Liner & Heaton, 2009).  
 
Assessment tools and normative data are rarely adapted to take cultural factors 
into account (Manly et al., 2011). For example, visual measures rather than 
verbal measures are found to have greater validity and reliability in rural China 
(Heaton et al., 2008). With normative data however, it has been suggested that 
even the ‘most representative norms’ do not include enough variance in factors 
such as intravenous drug use or mental health diagnoses to make the sample 
representative (Manly et al., 2011). Therefore even adapted norms must be 
considered fallible, and research to date needs careful interpretation. 
 
International neuropsychological research varies. Robertson and colleagues 
(2009) reviewed the literature available on HIV, finding many papers showed 
similar prevalence and phenotype of HIV-related cognitive impairment across 
cultures, countries and strains (see Robertson et al., 2009 for full description). 
For example, a study in Cameroon found PLWH displayed impairment in 
executive functions, information processing speed, working memory and memory 
recall, matching the profiles noted in the USA (Kanmogne et al., 2010) and rural 
China (Cysique et al., 2007). 
  
Other studies found differences between culture, ethnicity and HIV. For example, 
following adjustment for years in education and age, Manly and colleagues 
(2002) found that HIV-positive African-Americans had poorer neuropsychological 
outcomes than HIV-positive white Americans. However, this difference was lost 
after adjustment for scores on a reading test (the WRAT-3). The reading test may 
therefore be a better indicator of quality of education, and may account for cross-
cultural differences. However, in 2011 it was suggested that variance in cognitive 
 21 
 
scores between HIV-positive and HIV-negative individuals more significantly 
related to ethnicity and education than HIV status (Manly et al., 2011). The 
CHARTER study emulated this finding as ‘Hispanic1 ethnicity’ was associated 
with higher rates of, and earlier progression to cognitive decline in HIV-positive 
individuals when compared to non-Hispanic white and non-Hispanic black 
Americans (Heaton et al., 2015).  
 
Not expecting ethnicity-related findings, CHARTER explored possible reasons 
underlying their data. They highlighted the socio-political aspects of ethnicity, 
class and poverty within the USA. For example, people of Hispanic ethnicity have 
less access to health care and insurance (Adams, Kirzinger & Martinez, 2011; 
National Centre for Health Statistics, 2013), possibly leading to the finding that 
HIV-positive people of Hispanic ethnicity test (Chen, Gallant & Page, 2012; 
Dennis, Napravnik, Sena & Efron, 2011), obtain medical care for and initiate 
therapy (Turner et al., 2000) later than their American counterparts. Therefore it 
is possible that they are exposed to the disease for longer without knowing, 
accounting for discrepancies in the onset of HAND. Other factors such as 
housing, employment, education, and nutrition need to be investigated to identify 
whether these demographic variables explain the fluctuating findings in the 
literature regarding the impact of HIV on different cultures. 
  
The literature is littered with examples from both sides of the debate on the 
relationships between most demographic variables, HIV and cognition. What is 
becoming clear however, is the effect of social position and access to resources 
(the lack of which can increase cognitive decline, decrease resilience or 
conversely lead to false-positives in HAND diagnoses).  
  
Comorbidities  
In the recent CHARTER study, neurocognitive impairment increased with the 
presence of comorbidities. Specifically, prevalence of HAND rose from 30% (of 
individuals with no substantial comorbidity) to 60% when mild contributing 
comorbidities were present and 80% when confounding comorbidities occurred. 
                                            
1 This is the terminology used within the CHARTER study. 
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These latter findings occurred irrespective of CD4 count and viral load (Sacktor & 
Roberts, 2014). 
 
The main comorbidities investigated to date include Hepatitis C, substance 
misuse and mental health. Hepatitis C is shown to increase HAND through 
synergistic effects of the two illnesses which both target the CNS (e.g. Giesbrecht 
et al., 2014). Substance misuse has been described similarly, as most 
prescription and illicit drugs alter brain morphology, amplifying effects of HIV and 
subsequently HAND (e.g. Fama et al., 2011). Mental health has mainly been 
investigated in terms of its link to transmission rather than HAND. However, 
depression is known to affect motivation, verbal memory, executive functioning 
and motor performance (Castellon et al., 2006). Additionally, anxiety can affect 
processing speed, memory and cognitive flexibility during neuropsychological 
testing (Beaudreau & O’Hara, 2009), suggesting increased impairment would not 
be unusual.  
 
It is not within the scope of this study to explore all risk factors fully. For a richer 
description of comorbidities and other risk factors see appendix A.  
 
 
1.6 HAND and executive functions 
 
HIV affects multiple areas of cognition but has been described as a primarily 
dysexecutive syndrome (Weber, Blackstone, & Woods, 2013). Therefore 
executive functions will be addressed in more depth here.  
 
 
1.6.1 Executive Functions 
Multiple theories on the theoretical underpinnings of executive functions exist 
(e.g. Luria, 1973; Stuss & Benson, 1986; Damasio, 1995). One major theory is 
the Supervisory Attentional System (SAS; Norman & Shallice, 1986). It suggests 
that in general, behaviour is determined by ‘contention scheduling’, activation of 
schemas that are overlearnt, automatic behaviours triggered by routine events, 
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(e.g. ‘wanting to clean’ could be a schema activated when observing dirty plates). 
However, when presented with novel stimuli, situations or danger the SAS, which 
governs contention scheduling and higher order processes, influences schema 
activation and suppression. It then adapts previous behaviours to determine and 
generalise new rules and ways of being. 
 
Executive functions are summarised as higher cognitive processes which allow 
people to function in the world in a flexible, goal-directed, socially acceptable and 
effective manner. Lezak and colleagues (2012) separate these processes into 
two main categories: 1) concept formation, and 2) all other executive functions 
needed for goal-orientated behaviour.  
 
Normal executive functioning depends on the integrity of areas commonly 
affected by HIV including the frontal cortex, basal ganglia and connecting 
pathways (Stuss & Levine, 2002). It is not surprising therefore that executive 
function deficits are considered central to HAND. At present there are studies to 
suggest all aspects of executive function are affected in HIV. Not all agree which 
are specifically affected, or to what extent. A far greater body of evidence 
explores executive functions linked to goal-orientated behaviour and therefore a 
summary of this research will be presented before exploring concept formation.  
 
HAND and goal-oriented behaviour 
Goal-oriented executive functions link to volition, planning, decision-making, 
decisive action and effective performance (Lezak, Howieson, Bigler & Tranel, 
2012). They therefore include impulse control, planning, problem solving, fluency 
and working memory.  
 
Executive functions receiving interest and research in HAND include impulse 
control and decision-making. Bechara’s (2007) gambling task has evidenced 
impulsivity and poor decision-making in a number of studies (e.g. Martin et al., 
2004; Thames et al., 2012; Arentoft, Thames, Panos, Patel & Hinkin, 2013), 
specifically finding that PLWH chose larger, more immediate rewards instead of 
the gradually increasing smaller rewards chosen by HIV-negative individuals 
(Hardy, Hinkin, Levine, Castellon & Lam, 2006). Focused research into this area 
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may link to concerns that ‘risky’ decision-making may precede increased 
transmission of HIV. Planning has also been found to be impaired in HAND (e.g. 
Sahakian et al., 1995; Bartok et al., 1997; Cattie et al., 2012), in both 
symptomatic and asymptomatic individuals. These findings were replicated in 
assessment of functional abilities linked to social and activity planning using self-
report measures (Benedict, Mezhir, Walsh & Hewitt, 2000).  
 
Both letter and category fluency have been shown to be impaired in multiple 
verbal fluency tests (e.g. Iudicello et al., 2007, 2012). Verbal fluency impairments 
are considered the most frequently noted language deficit in HAND with up to 
40% of PLWH estimated to experience these difficulties (Rippeth et al., 2004). 
These impairments increase further when a switching component is added 
(Iudicello et al., 2008), which is unsurprising as impaired attentional control and 
rigidity in HAND have been noted in the Intra-Extra Dimensional Set Shift 
(Giesbrecht et al., 2014), Wisconsin Card Sorting Test (Carter, Rourke, Murji, 
Shore & Rorke, 2003) and Trail Making Test Part B (Heaton et al., 1995; Reger, 
Welsh, Razani, Martin & Boone, 2002).  
 
Furthermore, research looking into executive functions and disease stage have 
found spatial and verbal working memory impairments correlate with disease 
stage (e.g. Bartok et al., 1997; Martin et al., 2001), with fewer deficits noted in 
asymptomatic stages when measured using a computerised spatial working 
memory task (Grassi et al., 2014) and a visual vigilance task (Law et al., 1994). 
Difficulties with inhibition using the Stroop Color-Word Test (Tozzi et al., 1999; 
Hinkin et al., 1999) and sequencing through the WAIS-III Picture Arrangement 
(Melrose, Tinaz, Castelo, Courtney & Stern, 2008), are also demonstrated in late 
phases of HAND, however it is unclear at what stage these problems arise. 
 
HAND and concept formation 
Concept formation describes people’s ability to categorise objects and events 
based on their common properties, and then generalise these findings to other 
areas (Lezak et al., 2012). 
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The Halstead Category Test has indicated deficits of category sorting within large 
samples of PLWH (Heaton et al., 1995; Grant et al., 1987), which increases with 
disease stage and is noticeable in medically asymptomatic phases (Grant et al., 
1987). This test has subsequently been critiqued for oversensitivity and high 
levels of false-positives when testing patients with brain pathology (MacInnes, 
Golden, McFadden & Wilkening, 1983; Mitrushina, 2005; Larrabee, Millis & 
Meyers, 2008). Additionally, only one study has noted potential impairment in 
HAND linked to induction, a form of concept formation associated with 
recognising relationships, and rule acquisition and following (Johal, 2014). No 
further studies, known to the author, have focussed on this area. Therefore the 
literature on concept formation in HAND is limited.  
 
 
1.6.2 Critique of the executive function literature 
 
The evidence base 
Problematically, all studies linking HAND to goal-orientated behaviour and 
concept formation are based on short-term trials; providing only a snapshot of 
functioning in those assessed. Therefore, findings may not generalize over time. 
Domains (such as attention control, inhibition, decision-making and planning) that 
have multiple studies with similar findings could be said to be well evidenced. 
Other executive functions have had less attention including concept formation. 
Less explored areas will need further research to establish the validity of the 
currently available findings. Furthermore, while there is a study to indicate 
impairment for each executive function, not all agree which is most impaired. For 
example, one paper evidencing deficits in attentional flexibility and decision-
making did not find executive difficulties in other domains (Giesbrecht et al., 
2014). Discrepancies across studies may reflect different neuropsychological 
batteries, small sample sizes and methodological problems, or may reflect 
challenges with the concept of executive functioning itself.  
 
 
 
 26 
 
The concept of executive function 
Neuropsychological evaluation of executive functions have been critiqued since 
the impairment noted in testing does not always map onto functional ability. 
Rabbitt (2004) discusses this and suggests domains may overlap in testing or 
cortically. For example, diffuse (sub)cortical regions involved in each executive 
function means you cannot always predict impairment based on anatomical 
location of lesions. Conversely, Rabbitt also notes that executive functions could 
be more specific than currently understood, affecting interpretation of the 
neuropsychological results. Finally, skills may be overlearnt and therefore 
resistant to damage based on individual abilities rather than disease specific 
processes.  
 
These criticisms highlight the constructed nature of cognitive testing and 
neuropsychology. Specifically, executive functions are often discussed as 
discrete domains. However, they are concepts designed to capture functions and 
abilities expected of people in the modern world. The terminology does not 
represent a truth, but the current understanding and nomenclature used in order 
for professionals and others to communicate and measure phenomena appearing 
in clinics.  
 
Underlying difficulties in executive function and HAND 
Executive functioning relies on other intact abilities such as information 
processing and attention. This means qualitative analysis of clinical measures is 
needed to elucidate the multiple factors affecting performance on each test and 
may subsequently elucidate the factors Rabbitt (2004) referred to when 
discussing problems within the executive function literature. Significantly, little 
has been done to assess underlying processes of executive dysfunction in HAND 
(Woods et al., 2009), which is essential if we are to better understand the 
difficulties experienced by people, and target cognitive rehabilitation (Weber et 
al., 2013). 
 
This is in contrast to the expanding literature on deficits underpinning language 
and memory problems in HAND. For example, Woods and colleagues (2014) 
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found that diminished attentional resources underpinned problems with events-
based prospective memory in HAND, but that increased task importance afforded 
prioritisation of limited attentional resources. This suggested that disruption to 
medication regimens in HAND may link to the individual’s inability to attend to, 
and remember events that need to be carried out in the future. Subsequently, 
focussing on the importance of cART adherence with patients has been put 
forward as a strategy to improve prospective memory for required medication-
based actions (e.g. through use of rewards and reinforcement of beliefs regarding 
medication). 
  
To the researcher’s knowledge four studies to date have assessed and proposed 
mechanisms underlying executive functions impairment in HAND (verbal fluency 
is not included here as it is generally explored within language literature). Firstly, 
switching difficulties and fronto-striatal circuit damage have been suggested to 
underpin deficits in category fluency (Iudicello et al., 2008). Secondly, when 
depression and low mood are present in HAND they have been proposed to 
underpin ‘risky’ decision-making measured by the Iowa Gambling Task (IGT; 
Thames et al., 2012). This is purportedly due to depression’s link with decreased 
cognitive flexibility, cognitive resources and responsiveness to reward and 
punishment. Thirdly, and conversely, Arentoft and colleagues (2013) constructed 
a novel outcome measure for the IGT to categorise strategy use within the task. 
They found that inability to develop a strategy (problem solve) underpinned 
difficulties with decision-making rather than ‘risky’ or impulsive behaviour. Finally, 
lack of efficiency and accuracy in problem solving and rule-bound control has 
been identified as underpinning planning deficits measured by the Tower of 
London task (Cattie et al., 2012).  
 
These studies only used one task to investigate underlying deficits in each 
domain. Therefore, findings may pertain specifically to the task rather than 
cognitive domain, as it is hard to extrapolate other active neuropsychological 
abilities without a larger battery or other linked measure. They have also not yet 
been repeated, suggesting a necessary avenue for future research. 
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This current study was limited in terms of time and resources therefore one 
domain was selected in order to investigate underlying components affecting 
executive functions and address the gap in the literature regarding concept 
formation. This executive function is induction.  
  
 
1.6.3 Induction 
Central to human learning is the ability to detect relationships between events in 
our environment, and infer generalisable rules from abstract information (Holland, 
Holyoak, Nisbet, & Thagard, 1989). This ability, called induction or inductive 
reasoning, is often considered under the executive function, abstraction, and is a 
kind of multiple trial concept formation.  
 
The currently accepted process of induction, specifically linked to inferring and 
following rules, is thought to occur across multiple stages: 1) instance gathering 
and temporary memory storage; 2) recognition, and hypothesis generation, of 
similarities and relationships between items; 3) integration of new and old 
inferences; 4) information gathering to confirm hypotheses and allow future 
generalization of rules (Crescentini et al., 2011). Impairment in any of these 
stages would lead an individual to experience difficulties learning novel or 
generalisable information without explicit, concrete guidance and rule giving from 
another individual or text; significantly affecting independence and ability to adapt 
to the environment. 
 
 
1.6.4 Neuropsychological assessment of Induction  
The neuropsychological assessment tool most widely used to quantify inductive 
ability, at least relating to visuospatial rule acquisition from abstract information, is 
the Brixton Spatial Anticipation Test (known as the Brixton from this point 
forward; Burgess & Shallice, 1996). The Brixton was developed based on the 
SAS theory of executive functioning. It was intended as an alternative for the 
Wisconsin Card Sorting Test (WCST; Grant & Berg, 1948) because the authors 
felt the SAS theory suggested the WCST utilised aspects (colour, shape and 
number) with salient relationships outside of the task, activating schema 
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previously learnt and affecting performance. The exact method of the Brixton’s 
development is unclear as it is presented within its complete form in the initial 
paper, where it was utilised upon a group of 77 patients with anterior (frontal) or 
posterior (non-frontal) cerebral lesions.  
 
The Brixton consists of 55 visual items. Each of which have a rectangle drawn in 
the centre with ten circular outlines inside. On each page one of the circles is 
coloured blue. The blue circle moves around as the pages turn according to a 
rule, which changes over time. The participant must infer the rule and tell the 
examiner where the blue circle will go next. They must also notice when the 
pattern has changed and acquire the new rule. The rule changes eight times 
utilising a total of six rules (see appendixes B-J for an example of each set and 
rule).  
 
The test purports to be a more valid test of rule acquisition and following than the 
WCST as the rules relate solely to the presented cards, and no other stimuli 
needs to be previously understood. It is also suggested to be valid and reliable in 
terms of testing various patient groups, such as stroke, Korsakoff’s psychosis and 
dementia types including Alzheimer’s (Van Den Berg et al., 2009). Normative 
data is based on a sample of 118 hundred British participants (57 were males), 
whose ages ranged between 18 and 80. However, the norms are not age-
stratified. This is problematic as older age (60 years plus) is a known predictor of 
poorer performance on the Brixton (Andrés & Van der Linden, 2000). Normative 
data has subsequently been made for older adults (Bielak et al., 2006), yet none 
exist for the younger population.  
 
When used in an fMRI study investigating the neural correlates of induction it 
suggested that early stages of induction including rule search, acquisition and 
hypothesis generation are linked to activation in the mid-dorsolateral prefrontal 
cortex. Rule following has been linked to complex interactions in the temporal, 
motor, and medial/anterior prefrontal cortex. Activation in the frontopolar cortex 
has been noted throughout induction while a rule remains novel, switching off 
once a rule has been integrated and familiar (Crescentini et al., 2011). This was 
the first study to identify specific areas linked to induction and its stages, it was 
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also in line with previous findings that rule-guided behaviour depends on frontal, 
parietal, and temporal connections within the brain (Bunge, 2004; Bunge & 
Wallis, 2008). 
 
As induction is a complex skill requiring multiple intact networks, it is vulnerable 
to impairment following brain injury of any kind. Furthermore, these frontal 
regions are disrupted within HIV, rendering this a potential target within the 
disease.  
 
The Brixton does not possess a componential scoring system. Instead 
participants receive one overall score linked to performance, leaving it to others 
to consider underlying mechanisms during testing. In Johal’s (2014) doctoral 
thesis looking at executive functions affected in HAND, the author hypothesised 
that impaired induction, as measured by the Brixton, possibly linked to disruption 
of working memory and complex attention, both skills required in the task. The 
author also noted that participants struggled to develop and adjust strategies to 
manage the ever-changing rules in the task. The study looked at performance 
across multiple cognitive domains of 16 PLWH and HAND, and did not use a 
componential analysis. Therefore little is known about this executive function, 
whether Johal’s finding would be generalisable in other studies, or what 
underpins the impairment if it is indeed present in all experiencing HAND.  
 
 
1.7 Justification  
 
cART has decreased mortality rates and increased HAND, through a number of 
possible mechanisms not yet clearly understood. Neurocognitive impairment has 
led to decreased medication adherence and subsequent related illness, 
decreased employment rates, quality of life and ability to maintain independence. 
Even in its asymptomatic form HAND is considered to be a risk factor for ongoing 
problems. Vulnerability to HAND is also yet to be clearly understood but appears 
to link to populations already disadvantaged in terms of resources and access to 
health care. As the cohort of PLWH ages it is possible that the number of people 
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presenting to services with HAND will increase, creating increased need for 
effective treatment and related protocol. In order to meet this need greater detail 
is required regarding the profile of deficits linked to HAND, particularly the 
componential underpinnings of deficits present.  
 
The current literature asserts that executive functions are affected, and while not 
all of it agrees which specifically, evidence suggests that no executive function is 
resistant, at least in the later stages of HAND. Furthermore, aside from category 
fluency, decision-making and planning, little has been done to investigate the 
underpinnings of executive dysfunction. This needs to be addressed if the future 
of HAND is to be improved. Induction is one such executive function of which little 
is known with relation to HAND. It appears to be affected but it is unknown in 
what way and why. Problematically, current neuropsychological assessment tools 
such as the Brixton do not possess the required scaling systems to make 
componential analysis of results routinely possible. Therefore, development of 
subscales which aid componential analysis are also imperative.  
 
 
1.7.1 Aims  
This study aimed to address some of the gaps in the current HAND literature, 
such as HAND profiles linked to induction and underlying qualitative deficits 
causing impairment if any was noted. In order to do this the author aimed to 
develop an assessment measure that could be added to the current Brixton 
scaling system, which aids componential analysis and could be utilised more 
widely in the future. 
 
The literature has presented multiple, overlapping but not always coherent 
accounts of executive dysfunction in HAND profiles. Therefore impairment may 
be idiopathic and not represent a homogenous phenotype. If this is the case the 
research hopes to document this. Three research questions were identified at the 
start of the work and are as follows:  
 
1. Is induction disrupted in HAND when compared to a non-clinical population? 
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2. If induction is affected, is there a profile of disruption on measures of induction 
in HAND or does it differ by person? 
 
3. What underlying mechanisms do these deficits on measures of induction 
reflect?  
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2 METHODS 
 
 
2.1 Epistemology 
 
Epistemology is a branch of philosophy concerning itself with knowledge (Barker, 
Pistrang & Elliot, 2003). It questions the scope, reliability and validity of 
information people hold and believe to be true, through examination of the 
theoretical foundations upon which the information was sought or found (Willig, 
2008). 
 
The prevailing epistemological stance in contemporary scientific research is 
positivism. This asserts that logic and observation can lead us to truths about the 
world, its objects and phenomena (Willig, 2008). Therefore if something exists 
within the world it can be objectively verified by mathematics, the science of 
logical testing. For example, behaviourism was a major mode of positivist thought 
in the mid-20th century. Behaviourists studied only that which they could observe 
in others (i.e. their behaviour) and ignored, or denied the existence of, other 
postulated processes such as consciousness. Difficulties arose however as 
behaviourism was unable to continually predict and control others, which Trochim 
(2000) argues is the unspoken aim of positivist research. Therefore critiques 
have been raised that a positivist search for truth is reductionist, ignoring social 
and historical processes invisible to the eye but which may elucidate more 
reliable explanations.   
 
Conversely, a social constructionist epistemology asserts that there is no such 
thing as an external reality or ‘one truth’, but multiple ‘truths’, derived and given 
credence and meaning through their social context. Social constructionism would 
therefore argue that the search for ‘facts’ is futile as each finding will depend on 
the historical, political and societal factors of the time, which could shift moment 
to moment, dependent on the relationship and subjectivity of the researcher and 
its subject (Gergen, 1985).  
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The current research will be carried out from a critical realist position, which could 
be described as taking aspects from each of the two epistemological stances 
mentioned. Critical realism postulates that a reality exists outside of human 
thought and that research can be scientific. However it notes that objective facts 
may never be attained, particularly without acknowledgement of historical and 
social narratives, human error, systemic bias (Mackay & Petocz, 2011), and the 
potential impact of unobservable events. Due to, what is believed to be, fallible 
research methodology a critical realist should make use of multiple 
measurements and observations, and acknowledge the inherent cultural, 
professional and personal biases of researchers involved, and acknowledge that 
all theory is revisable. 
 
It is important to note that the aims and research questions used in this study 
more directly lend themselves to a positivist stance. However, a critical lens 
needs to be applied to research into this area in order to acknowledge multiple 
potentially immeasurable contemporary factors influencing neuropsychological 
research and HAND (e.g. socio-political factors), and the inherent biases of 
neuropsychological testing, devised, validated and continuously altered through 
western research. Therefore while this research aims for objectivity it is also 
critical of its methodologies and findings, using neuropsychological nomenclature 
with the understanding that this is the current accepted language through which 
findings can be discussed and shared.    
 
 
2.2 Design 
 
This was an exploratory study using mixed methodology. A quantitative cross-
section correlational design was used, in addition to a cases-series analysis of 
individual profiles. A qualitative component was also used to explore induction-
related responses pertaining to the Brixton. As no previous componential analysis 
of the Brixton indicating performance within the HIV-negative population exists, a 
control group was necessary to compare to the patient population’s performance.  
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Sample size was influenced by similar exploratory studies looking at, for 
example, sub cortical dementias (e.g. Abrahams et al., 2000). A power 
calculation was considered however the aim of the study was to explore effect 
size across and between groups, and sample size is described as relatively 
independent of the effect size (Clark-Carter, 1999). Furthermore, the study was 
constrained by time, resources and referral rate. Larger sample sizes are linked 
to more reliable, valid and powerful studies. Therefore the researcher aimed to 
acquire the largest sample size possible within the allotted constraints. 
 
 
2.3 Ethical approval 
 
Ethical approval was granted by the University of East London Ethics Committee 
(appendix K). For Mildmay UK, ethical approval was sought through the medical 
director and their committee. The service is not within the NHS and does not 
require IRAS/NRES ethical approval applications.  
 
All participants were required to give personal, written consent (see appendix L). 
Within the patient group the service’s consultant clinical psychologist provided 
assessment of capacity to consent. Written (see appendixes M and N) and verbal 
information about the study was provided to all potential participants to ensure 
informed consent. Information detailed that any choice made by the participant 
would have no bearing upon their clinical care. Should they decide to participate, 
their right to withdraw from the study at any time, without having to provide a 
reason and without impact on their medical care, was also clarified. Furthermore, 
confidentiality was explained (i.e. that following the assessment no identifiable 
information would be made available to anyone other than the researcher). 
 
To ensure anonymity, participants were assigned participant numbers that were 
used throughout data entry, analysis and this write up. A word document linking 
the participant name and number was created and kept separately, only 
accessible with a password. In accordance with the Data Protection Act (UK 
Parliament, 1998) test sheets were stored in a locked NHS filing cabinet and will 
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be destroyed after five years.  
 
 
2.4 Recruitment  
 
Patients were recruited from Mildmay UK, a neurorehabilitation centre in London. 
Mildmay UK offers specialist multidisciplinary care to PLWH and HAND in an 
inpatient and day service setting. It is the only centre in Europe dedicated to HIV 
and HAND.  
 
The HIV-negative control group was recruited through convenience sampling. 
Colleagues and contacts of the researcher were provided with the information 
sheet for the study and using a snowballing method others were informed. The 
control group was recruited to match, as closely as possible, the patient sample 
on a range of levels including age, years of education and premorbid IQ. 
 
 
2.4.1 Inclusion and exclusion criteria 
People referred to Mildmay UK present with varying medical and psychological 
conditions. To limit effects of confounding variables on neuropsychological 
performance, core inclusion and exclusion criteria were developed for 
participants irrespective of (criteria 1 – 3), and dependent on (criteria 4), group.  
 
Inclusion criteria 1 - Demographics:  
All participants were required to be between the ages of 18 and 65. The 
previously explained interplay between neuropsychological assessments, 
language and schooling meant participants were required to be fluent English 
speakers who had undertaken some formal education. 
 
Inclusion criteria 2 - Medical comorbidities:  
Participants were excluded if they held an active diagnosis of any illness known 
to acutely affect cognition, such as a urinary tract infection or hepatitis C. The 
patient group at Mildmay UK presented with multiple medical conditions affecting 
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cognition such as syphilis, toxoplasmosis, and tuberculous meningitis. The 
service’s consultant clinical psychologist therefore assessed patient suitability 
case-by-case, considering the cognitive impact of physical health statuses. 
Patients’ considered successfully treated for comorbid infections were invited to 
participate within the study. However, diagnoses linked to irreversible cognitive 
impairment or alteration (such as PML and CNS tumours) were excluded from 
the study. 
 
Inclusion criteria 3 – Psychological factors:  
Participants were excluded from the study if under the influence of illicit 
substances at the time of testing, or they presented with misuse-associated brain 
damage (e.g. Wernicke-Korsakoff's syndrome). They were also excluded if they 
had a ‘psychotic illness’ diagnosis, due to the impact this would have on 
functioning. Low mood and anxiety are common across the patient population 
within Mildmay UK. Therefore, case-by-case assessment of cognition and mood 
was carried out. If not deemed to impact functioning, low mood and anxiety alone 
did not stop inclusion into the study.  
 
Little research exists to date linking learning disabilities (LD) to HAND, however a 
diagnosis of LD was an exclusion criteria due to the implications of LD on 
cognitive performance, and informed consent.  
 
Inclusion criteria 4 – Factors linked to participant group:  
For the patient group, inclusion criteria required an HIV-positive diagnosis and 
symptoms indicative of HAND. For the control group, patients were required to be 
HIV-negative. 
 
 
2.4.2 Recruitment procedure  
 
HIV-positive population 
Upon admission to Mildmay UK the consultant clinical psychologist screens each 
patient. This enhanced selection of suitable participants as the current health 
status, and language ability of each inpatient was understood and monitored by 
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those in charge of recruitment selection.  
 
Neuropsychological testing is part of the standard assessment and treatment 
protocol at Mildmay UK. Therefore once the patient was deemed suitable for 
assessment they were provided with information about the routine procedure. 
Information included length of standard assessment (estimated at 1 hour) and 
subsequent procedures such as interpretation of results, report writing and 
impact upon medical care. Next, the patient was informed of a potential study 
they could participate in, adding 45 minutes onto testing time. They were 
provided with the information sheet and given as much time as they needed to 
consider it. Time was also given for discussion of the study and any questions 
they wished to pose. If they then wished to participate they were asked to sign a 
consent form. 
 
Control population  
Once identified, potential participants were approached by email and sent the 
information sheet, details of the study such as assessment length (approximately 
30 minutes) and consent form. They were given 24 hours, or longer if needed, to 
consider participation and questions they wished to have answered. A face-to-
face meeting was set up for discussion of the study, before written consent was 
given.  
 
 
2.5 Materials 
 
The full test battery (see table 1) included measures of premorbid functioning and 
mood, current cognitive status and executive functioning, including two tests of 
induction. The HIV-positive group undertook the complete battery, while the 
control group only completed tests of premorbid functioning and induction. 
 
 
2.5.1 Premorbid function 
The ability to read irregular words is believed to be resistant to cognitive 
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impairment (Strauss, Sherman & Spreen, 2006) at least until the later stages of 
neurodegeneration. Performance on a test of irregular word reading is therefore 
thought to represent a snapshot of pre-impairment cognitive functioning. This is 
supposed as words cannot be read correctly through phonemic pronunciation 
and correct performance relies on previous knowledge of the word, rather than 
knowledge of grammatical rules. The test relies on normal reading skill 
development prior to impairment. 
 
The Wechsler Test of Adult Reading (WTAR; Wechsler, 2001) is made up of 50 
irregular words that participants have to read aloud and pronounce correctly, 
there is no time limit. Answers provided by participants are marked on a pass/fail 
basis. Overall scores are then compared to normative data to achieve an index 
function score. Normative data is based on a sample of 1,134 American and 331 
British participants deemed to be representative through census data. The 
American sample, aged 16-64, were equally spread between men and women. 
Those over 64 were mainly female. The sample from the UK was also majority 
female.  
 
 
2.5.2 Mood  
Hospital Anxiety and Depression Scale (HADS; Zigmond & Snaith, 1983) 
Participants are asked to rate themselves on fourteen items, seven linking to the 
symptoms of anxiety and seven to depression. A separate score is acquired for 
each of these constructs. Scores are stratified to identify ‘suspicious cases’ (a 
score of 8 or more) and ‘safe cases’ (a score of 11 or more). As anxiety and 
mood affect cognitive performance this was used to inform interpretation of the 
neuropsychology outcomes. Normative data is based on 810 male and 978 
females ranging between 19-91 years in age (Crawford, Henry, Crombie & 
Taylor, 2001). Good reliability and validity has been shown for patients in hospital 
(Herrmann, 1997). 
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2.5.3 Current functioning  
The Repeatable Battery for the Assessment of Neuropsychological Status 
(RBANS; Randolph, 1998)  
The RBANS has 12 subtests and assesses cognitive status in neurological 
disease and dementia, with good reliability and validity (Hodges, 2007). It was 
chosen for this study as Mildmay UK uses it in routine assessment, meaning 
clinical utility for the service and patient was maintained and that any patient 
opting out of the study still received standard care. Furthermore, the RBANS 
covers areas associated with HIV and other dementias, meaning differential 
diagnosis could be made if necessary (e.g. Alzheimer’s). It is also relatively quick 
(approximate test length is 45 minutes) and easy to administer at the bedside of 
the participant (Lezak et al., 2012), which suits the assessment setting. 
Furthermore, employing a single battery for the majority of the assessment meant 
co-normed results enhancing comparability of test results.  
 
The RBANS’ normative data is based on a sample of 540 Americans ranging 
from 18 to 89 years old. The sample was 81% white American, 13% African 
American and 7% Hispanic Americans. RBANS subtests are discussed below, 
separated by cognitive domain:  
 
1. Attention:  
i) Digit Span Forward 
To assess attention and short term stores, participants’ are read number strings 
of increasing length that they must repeat back verbatim.  
 
ii) Coding 
To assess attention and information processing speed, participants are given a 
page with a printed key showing nonsense symbols paired with numbers. Below 
the key are continuous rows of symbols without their corresponding number. 
Participants need to identify the missing symbol, entering it into the boxes below 
as quickly as they can. 90 seconds are given for the task. 
 
2. Immediate Memory: 
i) List Learning 
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To assess verbal learning, participants are read a list of 10 unrelated words that 
they must try to recall. There are four trials of this task.  
 
ii) Story Learning 
To assess episodic memory, participants are read a story comprising 12 linked 
items, which they must repeat back with as much detail as they can recall. There 
are two trials to this task. 
 
3. Visuospatial:  
i) Figure Copy 
To assess visuospatial perception and construction, participants are given a 10 
component complex design that they must copy directly.  
 
ii)  Line Orientation 
To assess visuospatial perception, participants are asked to identify the location 
of two lines presented to them, based on a key of 13 lines spreading across 180 
degrees from a single origin. There are ten trials within this task.  
 
iii) Figure Recall 
Following a 20-minute delay, participants are asked to redraw as much as they 
remember from the Figure Copy task. This is a visuospatial memory task.  
 
4. Verbal: 
i) List Recall 
Following a 20-minute delay, participants are asked to recall any words they 
remember from the List Learning task. This is a verbal memory task. 
 
ii) List Recognition 
Participants are read a list of 20 words and asked to identify words present in the 
initial List Learning task. Ten words originate in the List Learning task, the other 
ten are distracter items. This is a verbal memory task. 
 
iii) Story Recall 
Following a 20-minute delay, participants are asked to recall as much detail as 
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they can from the initial Story Learning task. This is a verbal memory task. 
 
5. Language: 
i) Picture Naming 
In this naming-to-confrontation task participants must name the items presented 
in ten images.  
 
ii) Semantic Fluency 
To assess semantic fluency participants have to name as many items within a 
specific category as possible within 60 seconds. 
 
 
2.5.4 Executive function 
The RBANS misses certain important features of executive functioning. For 
example semantic fluency is assessed, but not letter fluency. Furthermore, 
visuospatial working memory and single or multiple trial concept formation are not 
assessed. Therefore additional measures were included: 
 
1. Verbal fluency: 
The Verbal Fluency Test (D-KEFS; Delis, Kaplan & Kramer, 2001). 
Different aspects of verbal fluency are assessed across three stages. 
  
i) Word generation and letter fluency: Verbal Fluency Test 
This subtest assesses skills in word generation. Participants must generate as 
many words as possible within 60 seconds starting with a given letter, which 
changes across trials (‘F’, ‘A’, ‘S’). Successive words must not share the same 
prefix, be numbers, or names of people or places. The number of words 
generated that adhere to the rules makes up the final score. 
 
ii) Category fluency: Semantic Fluency Test 
This subtest assesses semantic retrieval strategies and word generation. 
Participants must generate as many words as possible within 60 seconds that 
link to a provided category, which changes across trials (‘animals’ and ‘boys 
names’). The number of words generated makes up the final score.  
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iii) Switching: Switching test  
This subtest assesses ability to switch attention between tasks, and verbal 
fluency. Participants must switch between two given categories (‘fruit’ and 
‘furniture’), generating a word from each category each time they switch. They 
have 60 seconds. The number of words generated that fall into the two 
categories makes up one score. Another score counts the number of times the 
person accurately switches between categories. 
 
Each score is compared to the DKEFS normative data. This data is based on a 
sample of 1,750 Americans whose ages range between eight and 89 and were 
considered to be representative of the American population in terms of ethnicity. 
Males and females are equally represented within the younger age groups, 
however, more females participated in the older age group. 
 
2. Visual Working Memory: 
Spatial Span (Wechsler Memory Scale – third edition [WMS-III]; Wechsler, 
1997a) 
This test assesses visuospatial short-term memory. A page with randomly 
positioned printed spots is presented to the participant. The assessor touches the 
spots in a sequence that increases in length over each trial. The participant must 
copy the pattern exactly in order to score points.  
 
Normative data is based on a sample of 700 Americans, 78% white Americans, 
53% female, all aged between 20 and 89 years of age.  
 
3. Visual abstract reasoning: 
Matrices Reasoning (Wechsler Adult Intelligence Scale - third edition [WAIS-III]; 
Wechsler, 1997b).  
This is a visual test of single trial concept formation. Participants are presented 
with a series of figures that are linked through a discernable pattern on each item. 
One figure is missing and the participant must decide from a list of possibilities 
which figure completes the pattern. 
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4. Verbal abstract reasoning: 
Similarities (WAIS-III; Wechsler, 1997b). 
This is a verbal test of single trial concept formation. Participants are read two 
semantically linked words (for common objects or concepts). There are 19 pairs 
of words in total. The participant must explain the way in which the words are 
similar. Many words may seem dissimilar. It is the role of the participant to 
abstract the superordinate relationship of the two items. 
 
Normative data for the WAIS-III is based on a sample of 2,450 adults considered 
to be representative of the US population in terms of ethnicity.  
 
 
2.5.5 Induction 
1. Visuospatial induction:  
The Brixton Spatial Anticipation Test (Burgess & Shallice, 1996). 
The Brixton is described within the introduction. The total number of errors made 
across the test comprises the overall score, which is then compared to normative 
data.  
 
2. Verbal induction:  
The Word Context Test (D-KEFS; Delis et al., 2001) 
This test assesses verbal multiple trial concept formation and has nine trials. In 
each trial a mystery word is given and the participant must determine the 
meaning of the word. The mystery word is presented alongside an initial clue 
sentence, which hints at the meaning of the word. The participant must make a 
guess at the meaning of the word. Five clue sentences are given in total and the 
participant must continue to guess after each clue is given. 
 
Scores include the total number of consecutively correct answers, repeated 
incorrect answers and ‘no/don’t know’ responses. Only consecutively correct is 
used within this study, and compared to the DKEFS’ normative data. 
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Table 1. Neuropsychological test battery 
 
Test component Cognitive Domain Subtest 
1. Premorbid functioning  WTAR  
2. Mood  HADS 
3. Current Functioning Attention Digit Span Forward* 
*RBANS   Coding* 
 Immediate Recall  List Learning* 
  Story Learning* 
 Visuospatial Figure Copy* 
  Line Orientation* 
 Delayed Recall List Recall* 
  List Recognition* 
  Story Recall* 
  Figure Recall* 
 Language Picture Naming* 
  Semantic Fluency 
4. Executive Functioning Verbal Fluency DKEFS Verbal Fluency 
  DKEFS Category Fluency 
  DKEFS Switching 
 Working Memory WMS-III Spatial Span 
 Abstract Reasoning WAIS-III Matrices Reasoning 
  WAIS-III Similarities 
5. Tests of Interest Induction Brixton Spatial Anticipation 
Test 
  DKEFS Word Context Test 
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2.6 Test Procedure 
 
Prior to testing, all participants were interviewed to gain a general history. This 
covered the number of years they spent in education, occupational trajectory, 
languages spoken, health status and mood-related factors. Impairments 
potentially affecting performance, such as eyesight and motor control, were also 
discussed. 
 
 
2.6.1 HIV group 
All patients were tested in their hospital rooms. Medical information was gathered 
from medical files with permission of the participant. The full battery was 
administered following each test’s protocol. A break was offered 45 minutes into 
testing to alleviate fatigue and ensure the required time had elapsed between 
immediate and delayed recall tasks. Verbal debriefing was offered immediately 
after assessment.  
 
Participants were given feedback on their assessment scores through a brief 
written report, and verbal discussion if still on the ward following assessment. The 
summary included strengths, difficulties and recommendations. With consent, full 
reports were then sent to their HIV consultant and clinical nurse specialist.  
 
 
2.6.2 Control group 
Participants were tested in separate clinic rooms within Mildmay UK, or in the 
home of the participant. If at home it was ensured that quiet spaces were 
available where the test could be completed without distraction.  
 
In addition to formal test procedures, extra information was gathered during the 
Brixton test in each group.  For example, qualitative descriptions of participant 
behaviour were noted. Information included hesitation and verbal comments. 
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2.7 Analysis 
 
2.7.1 Quantitative analyses 
Data collected was scored through methodology set out in each test’s respective 
manual, and raw and age-scaled scores (scaled scores and subjective ranges 
were based on Slick, 2006; see appendix O) were entered into the Statistical 
Package of Social Sciences version 20 (SPSS). The small sample size, and 
proportion of ordinal data, indicated the necessity of non-parametric tests in 
exploratory analysis when exploring data collected. SPSS procedures, 
bootstrapping and resampling were used to produce exact tests. This gave rise to 
exact significance values, indicating the proportion of times the results found 
within the data would be repeated if the test was run including all possible 
variations. Therefore no asymptotic p values are provided.  
 
Correlational analyses were used to identify relationships across group 
characteristics, including age and language.  
 
Case series analyses were used to identify patterns within individual profiles.  
 
 
2.7.2 Qualitative/componential analyses 
Experimental psychology has demonstrated the subcomponential facets of 
cognitive domains (Neisser, 1967), suggesting that all information processed 
passes various cognitive components and processes. Componential analysis is 
utilised in psychometric testing to create scoring systems (e.g. Delis, Squire, 
Bihrle & Massman, 1992) that identify these subcomponents and structural 
variables (items within a task where the component can be seen to occur and can 
then be quantified; Clark & Gardner, 1990). The tests are then scored based on 
these aspects. Additional reference testing (use of other neuropsychological 
tests) can be undertaken to identify other contributing variables in the 
componential analysis.  
 
No componential scoring system exists for the Brixton. Instead people receive 
one total error score. However, Burgess and Shallice (1996) define three 
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separate features of error performance: perseveration, misapplication of strategy 
and bizarre. Little information exists to explain the exact characteristics of these 
errors and what it means to score under the category of misapplication of 
strategy, but a perseverative or bizarre answer may be more self-explanatory.  
 
Other tests have validated componential scoring systems measuring similar 
domains. For example, the WCST derives a score for multiple areas (Heaton, 
Chelune, Talley, Kay & Curtis, 1993) including: 
 
 number of categories completed, 
 trials to complete first category, 
 perseverative responses, perseverative errors, 
 failure to maintain set, 
 percent conceptual level responses, 
 learning to learn.  
 
Each scoring domain has a specific methodology, which can be followed by all 
using the test. Furthermore, the Brixton test involves visuospatial perception and 
short-term memory suggesting that aspects of these areas of cognitive 
functioning may be reflected in performance.  
 
In order to derive componential analysis for the Brixton, the researcher noted 
qualitative information pertaining to performance on the task, such as comments 
made by the participant during testing. After collection, this data and the scored 
tests were explored for errors and styles of response arising across the test. 
Analysis was both deductive and inductive as the Brixton tests were coded in 
three stages for: 
 
 error types outlined by Burgess and Shallice, 
 error types outlined by the WCST system, 
 any other themes or error types arising from participant’s performance 
during testing and their score sheets. The researcher derived these 
codes.  
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Every answer given by a participant was analysed for performance strategy and 
resemblance to expected answers. Once a list of codes and structural variables 
(i.e. method through which this code was identified) was created, every test was 
re-marked to quantify the number of trials across which each theme arose. Codes 
were collapsed into overarching themes if it seemed they pertained to the same 
response type. These numbers were then entered into SPSS where they could 
be explored statistically. It should be noted that errors were thought to be 
operationalised aspects of the componential factors at play within the task, hence 
focussing on these aspects. 
 
Tests within the full neuropsychological battery measured memory, visuospatial 
skills and single trial concept formation, all of which link to Brixton performance. 
These were cross-referenced with performance on tests of interest.  
 
 
2.7.3 Participant Characteristics 
Within the allotted timescale 15 HIV-positive patients met criteria for the study. 
One candidate declined neuropsychological assessment, both for routine medical 
care and the study. The other candidates consented to take part. One participant 
withdrew from the study after assessment, as he was unhappy with the results of 
his neuropsychological examination. Therefore 13 people made up the HIV-
positive group. The control group was recruited to achieve a matched sample, 
therefore 13 controls were assessed leading to a total of 26 participants. Age, 
years of education and other demographic variables for each group are 
presented in Table 2 (full information is in appendixes P-Q)  
 
Of all participants seven were female and 19 male, meaning an 
overrepresentation of males within the study and a significant difference between 
sexes, X2 (1) = 5.538, exact sig. = .029. A chi-square test (see table 3) indicated 
that the male to female ratio was the same in the HIV and control population. A 
Mann-Whitney U test on participant data (see table 4) indicated the groups were 
well matched for age, years of education and reading ability (as assessed by the 
WTAR). While not significantly different, the control group scored slightly higher 
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on the WTAR, approximately one to one and a half scaled score points above the 
HIV group. 
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Table 2. Participant characteristics 
 Group Min Max Mean SD 
Age (Years) HIV* 
 
38.0 65 51.38 8.91 
 Control** 32.0 65 50.00 11.37 
Education 
(Years) 
HIV 6.0 21 14.08 3.66 
 Control 8.0 18 14.15 2.97 
WTAR 
 
HIV 5.0 14 8.69 3.10 
 Control 5.0 14 10.08 2.66 
HADS 
Anxiety 
HIV 2.0 12 6.69 3.199 
 Control - - - - 
HADS 
Depression 
HIV 1.0 13 5.46 2.961 
 Control - - - - 
Recent CD4 HIV 24.0 400 178.69 122.296 
 Control - - - - 
Nadir CD4 HIV 17.0 308 111.15 85.737 
 Control - - - - 
Viral Load HIV 40.0 511214 70436.62 144929.720 
 Control - - - - 
Years since 
diagnosis 
HIV 0.5 24 10.153 9.233 
 Control - - - - 
*HIV group = 3 female, 10 male 
**Control group = 4 female, 9 male 
 
Table 3. Correlational analysis of gender and language distribution across groups 
Group Pearson’s Chi-Square Df Exact sig. (2-sided) Phi Exact Sig.  
Gender .195 1 1.000 -.087 1.000 
Language .722 1 .673 -.167 0.673 
 
Table 4. Comparison of participant characteristics 
 Mann-Whitney U Z Exact Sig. (2-tailed) 
Age (Years) 76.00 -.437 .677 
Education (Years) 79.500 -.259 .810 
WTAR (Scaled) 61.500 -1.187 .246 
 
Table 5. Effect of primary language on the WTAR and Word Context Test 
 Mann-Whitney U Z Exact Sig. (2-tailed) 
WTAR (scaled) 39.00 -1.189 .242 
Word Context Test (Scaled) 21.00 -2.392 .016 
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Primary language varied across participants but the ratio was not found to differ 
between groups (See table 3). In the HIV group, participants whose primary 
language was English were born in the UK (n=5), Kenya (n=1), Uganda (n=1) 
and Portugal (n=1). Participants whose primary language was not English, yet 
presented as fluent, were born in Ghana (n = 1), Nigeria (n = 1), Uganda (n=1) 
and Ethiopia (n=2). In the control group, participants whose primary language 
was English were born in the UK (n=9) and South Africa (n=1). Non-primary 
English speakers were from India (n=2) and Portugal (n=1).  
 
The WTAR and Word Context Test were used across both groups and rely on 
English language and related-cultural knowledge. Therefore, a Mann-Whitney U 
test was carried out to explore the relationship between primary language and 
performance on these tests (see table 5). No concern was noted in terms of 
primary language and premorbid functioning. However, those whose primary 
language was English performed significantly better on the Word Context Test 
suggesting care must be taken when interpreting results based on this test. 
 
Within the HIV group, 11 participants presented with comorbidities including 
previously diagnosed and treated tuberculosis (n = 2), syphilis (n=2) and C-Diff 
(n=1). Ongoing comorbidities included Kaposi’s sarcoma (n=1) and pain 
conditions (n = 2). Three participants had previously been treated for depression 
and remained on medication, and two for substance misuse where treatment had 
been deemed successful. HADs scores indicated one person met criteria for 
depression and anxiety (participant 10), and one for anxiety (participant 7); 
neither of these were being treated for either condition. Within the control group 
only three participants presented with comorbidities: hyperthyroidism, a pain 
condition and diabetes. 
 
Time since HIV-positive diagnosis, most recent CD4 count and nadir CD4 count 
were also collected and are presented in table 2. The most recent CD4 count for 
each participant depended on testing within the service. Therefore this cannot be 
relied upon as an accurate measure of illness stage.  
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3 RESULTS 
 
 
3.1 Exploratory data analysis  
 
Data were explored within SPSS, firstly to identify errors and secondly to 
determine distribution of variables and whether they met the assumptions 
required for parametric analyses. Boxplots and histograms were appraised for 
outliers and coding errors and any coding problems identified were corrected.  
 
 
3.2 Exploratory analysis of cognitive functioning within HIV group 
 
Both raw and age-scaled scores were reviewed in the initial exploration of 
cognitive data. Age-scaled data were used for final analysis, since it accounts for 
age-related variance in neuropsychological performance. However the Brixton 
lacks age-stratified norms; this must be noted when interpreting the following 
data. Descriptive statistics and the Kolmogorov-Smirnov (KS) test were used (see 
table 6) to explore the HIV-positive group’s performance on the cognitive battery 
and assess whether distribution of scaled scores within the group matched age-
scaled normative data (Mean = 10, SD = 3).  
 
Inspection of mean age-scaled scores for each subtest within the HIV group 
indicates a profile of impaired functioning across all domains. Mean scores for the 
visuospatial RBANS tests (Figure Copy and Line Orientation) lie closer to the 
normative mean of ten. Additionally performance on Similarities, Matrices 
Reasoning and Spatial Span, while weaker than the visuospatial domain, also lie 
within one standard deviation of the normative mean. 
 
KS results indicate that apart from Figure Copy and Line Orientation, which fell 
into the normative range, participants’ scores were significantly lower than the 
normative sample on all tests of cognition. This is to be expected in an HIV-
neurologically impaired population, where visuospatial processing is often found 
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to remain relatively intact. Although significantly different to normative data, KS 
scores indicated that performance on a few tests was less substantially impaired 
than others. Reported in order of increasing difference from the normative, these 
tests were Similarities, Picture Naming, Matrices Reasoning and the Brixton. 
Performance on these tasks link to visuospatial skill, language and single trial 
concept formation, skills required in the Brixton. 
 
 
 
Table 6. Descriptive statistics and distribution of current functioning in HIV group 
compared to normative data (Mean = 10, SD = 3) 
 Mean SD Min Max Kolmogorov-
Smirnov 
p 
RBANS List Learning  4.31 2.529 1  9 2.479 .000 
RBANS Story Learning 4.31 1.888 2  8 2.756 .000 
RBANS Figure Copy 8.92 4.368 1 14   .887 .411 
RBANS Line Orientation 8.62 4.134 3 15 1.214 .105 
RBANS Picture Naming 6.77 4.604 1 12 1.613 .011 
RBANS Coding 2.15 1.345 1 5 3.433 .000 
RBANS Digit Forward 6.46 2.634 2 11 1.996 .001 
RBANS List Recall 3.75 3.306 1 11 2.519 .000 
RBANS Story Recall 4.08 2.712 1  9 2.433 .000 
RBANS Figure Recall 6.33 2.387 3 11 2.337 .000 
RBANS List Recognition 4.75 4.938 1 12 2.231 .000 
DKEFS Letter Fluency 5.46 2.222 1  9 2.479 .000 
DKEFS Category Fluency 4.00 3.109 1  9 2.418 .000 
DKEFS Switching Total 3.69 3.881 1 12 2.722 .000 
DKEFS Switching Accuracy 4.31 4.289 1 12 2.183 .000 
WAIS Similarities  7.83 3.380 3 15 1.471 .026 
WAIS Matrices Reasoning 7.33 2.309 4 12 1.723 .005 
WMS Spatial Span 7.17 1.586 5 9 2.184 .000 
Brixton   5.18 3.628 1 10 1.790 .003 
DKEFS Word Context  3.85 3.262 1 11 2.722 .000 
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3.2.1 Contribution of executive function to HIV group Brixton performance  
Multiple regression was used to compare the relative contribution of visuospatial 
perception (Figure Copy), visuospatial memory (Spatial Span) and verbal multiple 
trial concept formation (Word Context Test) to Brixton performance (see table 7). 
No significant relationship or predictive value was found for any predictor 
variable.  
 
 
Table 7. Multiple regression of predictor variables and Brixton performance  
Predictors B Std. Error ß t Sig. 
Figure Copy -.222 .304 -.314 .728 .494 
Spatial Span -.305 .880 -.140 -.347 .740 
Word Context .421 .381 .425 1.103 .312 
 
 
 
3.3 Group comparison - measures of induction  
 
A Kolmogorov-Smirnov test was carried out on control group data to assess 
whether they performed within the normative range (see table 8). The results 
indicated that control group performance matched the normative distribution for 
the Word Context Test but not the Brixton. The distribution curve for the control 
group’s Brixton performance was higher than the norm. This suggests 
visuospatial induction was superior to verbal-based induction within the control 
group. This needs to be taken into account when interpreting the following data.  
 
Tables 9 and 10 present descriptive statistics and Mann-Whitney U test results 
for the HIV and control group on tests of induction. Two participants in the HIV 
group did not complete the Brixton due to reports it was too difficult for them to 
finish. Therefore percentages of correct answers out of total trials completed 
were calculated (see table 9) so as to include all participant data. Percentage 
scores are not adjusted for age and therefore must be interpreted with caution. 
The results (table 10) indicated that the control group scored significantly higher 
 56 
 
on Word Context Test scaled scores, and Brixton scaled and percentage scores. 
The effect size (Z scores) for both tests were similar across tests also. 
 
 
 
Table 8. Descriptive statistics and distribution of Control Group performance on 
tests of Induction compared to normative data 
 Mean SD Min Max Kolmogorov-
Smirnov 
p 
Brixton (scaled) 12.31 2.594 8 16 1.586 .013 
Word Context (scaled) 11.23 2.651 7 16 1.055 .216 
 
 
Table 9. Descriptive statistics of performance on tests of induction for both 
groups 
 Group Mean SD Min Max 
Brixton (Scaled) HIV 5.18 3.628 1 10 
Control 12.31 2.594 8 16 
Brixton (Percentage) HIV 51.30 13.342 29 69 
Control 77.22 9.652 62 91 
Word Context (Scaled) HIV 3.85 3.262 1 11 
Control 11.23 2.651 7 16 
 
 
Table 10. Comparison of group performance on tests of induction 
 Mann-Whitney U Z Exact Sig. (2-tailed) 
Brixton (Scaled) 9.500 -3.613 .000 
Brixton (Percentage) 13.000 -3.674 .000 
Word Context 8.000 -3.954 .000 
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3.4 Componential Analysis of Brixton performance 
 
Qualitative appraisal of Brixton performance started during testing. Early on it 
became apparent that three areas could be coded separately when exploring the 
compiled data, to elucidate different aspects of performance across the groups:  
 
 Assessment of performance across the Brixton as a whole exploring 
abilities expected by the task, including rule detection and switching to 
further rules (referred to as ‘overview’). 
 Assessment of specific errors made (error-by-error) and underlying 
processes/strategies used to arrive at this answer (referred to as ‘reasons 
underlying errors’). 
 Assessment of patterns of responding across the test, other themes not 
obviously noted as part of the test (referred to as ‘anything else’). 
 
Themes and strategies that were coded consistently across tests were compiled 
into a scoring system through which all tests were re-marked (see Table 11). An 
example of the general Brixton scoring form is provided in appendix R, followed 
by an example of a completed Brixton test scored using the new componential 
system (appendix S). It was decided that codes should not go ‘beyond the 
description’ (Wittgenstein, 1958) of observed behaviour, to limit the level of 
interpretation necessary at this stage. Therefore, for example, ‘misapplication of 
strategy’ was not utilised, as ‘reverting to a previous rule’ appeared to better 
describe performance. Also ‘bizarre’ was not utilised as a final code as the 
participant may have utilised a strategy that was not observable to the 
researcher; instead the term ‘no observable strategy’ was used. 
 
 58 
 
Table 11. Codes noted in componential analysis and methods of measurement 
Themes and codes How measured Additional information 
Overview 
1. Rule acquisition Number of rules acquired out of 6 - 
Number of sets acquired out of 9 - 
1a. Speed of rule acquisition  
(could also reflect speed of shift). Number of trials taken to acquire rules in total 
Add up all errors within a set until two consecutive correct 
answers indicate rule is acquired (if rule never acquired all 
trials within that set will be counted) 
2. Shifting Number of shifts achieved out of the 8 required in the test - 
3. Rule following - Set-loss 
Number of times a set is lost after rule acquired   
Add up all times an error is incurred part way through the set 
(this is the total). 
3a. Reasons for set-loss Set-loss due to participant anticipating rule change Trials participant verbalized they expected the rule to change 
Set-loss due to participant not managing 1-10 shift or vice versa 
On trials 11, 24, 27 & 30 the circle reaches the end of the line, 
add number of times error occurs on these trials.  
Set-loss due to participant reverting to 10-5 rule 
On trials 24, 28, 30, 35, 37, 39 & 41 (after set 3), add up times 
participant reverts to this rule when another 10 or five is shown. 
Set-loss not accounted for by another observable reason  - 
3b. Regaining set 
Number of times they manage to regain set immediately after losing set 
Add the number of times a set-loss if followed by a correct 
response.  
Exploration at the single error level 
4. Total errors Total number of errors  This is also the raw score 
4a. Perseveration  Number of trials participant perseverates with the previous set rule after 
pattern changes 
- 
Number of repeated answers  
Add the number of times participant repeats answer. Does not 
include repetition of number 9 in rule 5  (set 8) 
4b. Reverting to a previous rule  Number of times errors link to use of a previous rule   Guessing trialling previous rule (e.g. -1, +1, 10-5) 
4c. 1-10 shift 
Number of times errors link to 1 to 10 shift  
This may be different to set-loss section as errors may not 
have led to set-loss.  
4d. Response capture Number of times error is the person saying the number on the page Do not monitor this response in rule 5 (set 8) 
4e. No observable strategy Number of answers that have no strategy obvious to observer - 
Themes emerging linked to patterns of responses 
5. Monitoring  Number of trials participant did not realise the rule had changed and 
continued responding to previous rule and stimulus. Did not realise 
responses wrong. 
If a pattern of responses occur which do not link to visual 
stimuli but to the participant’s previous response (e.g. says 7, 
8,9,10 when pattern changed after 7) add up these trials. 
Numbers of trials participant continues to use an incorrect strategy 
when visual stimuli indicate strategy is wrong.  
If a pattern of incorrect strategy use occurs (e.g. using +1 
strategy repeatedly with incorrect answers) add up number of 
trials after pattern initiated. 
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Table 12. Descriptive statistics of performance on the Brixton test across groups 
Theme Measure Group Mean SD Min Max 
1. Rule detection Rules acquired (out of 
6)  
HIV 3.46 1.808 1 6 
Control 5.85 .376 5 6 
Sets acquired (out of 
9) 
HIV 5.31 2.658 1 9 
Control 8.85 .376 8 9 
1a. Speed of 
acquisition 
Total trials to acquire 
rules  
HIV 25.36 10.122 12 39 
Control 10.38 5.268 4 18 
2. Shifting Shifts achieved (out of 
8) 
HIV 4.08 2.691 0 8 
Control 7.85 .376 7 8 
3.Sets Lost 
Number of sets lost 
HIV 1.82 1.537 0 5 
Control 2.23 1.092 1 5 
3a. Set-loss 
reasons 
No observable reason  
HIV .64 .809 0 2 
Control .23 .439 0 1 
Anticipation  
HIV .18 .405 0 1 
Control .77 1.092 0 4 
1-10 shift 
HIV .64 .809 0 2 
Control 1.08 .494 0 2 
10-5 rule 
HIV .36 .505 0 1 
Control .15 .376 0 1 
3b. Sets 
regained 
Number sets regained  
HIV .91 1.044 0 3 
Control 1.38 .650 1 3 
4. Total Errors 
Total errors  
HIV 25.91 7.463 17 39 
Control 12.54 5.301 5 21 
4a. 
Perseveration 
Perseveration with 
rule just finished 
HIV 6.18 9.837 0 33 
Control 2.54 1.984 0 6 
Repeated answers  
HIV 3.00 2.324 0 7 
Control .85 1.144 0 4 
4b. Reverting 
previous rule 
Revert to previous 
rule  
HIV 6.09 3.081 0 11 
Control 5.69 2.594 3 10 
4c. 1-10 shift 
 1-10 shift  
HIV .64 .809 0 2 
Control 1.46 .776 0 3 
4d. Response 
capture 
 Saying number on the 
page 
HIV .31 .630 0 2 
Control 0 0 0 0 
4e. No Strategy No observable 
strategy  
HIV 10.91 10.397 0 35 
Control 2.38 2.022 0 6 
5. Monitoring  Did not realise rule 
change/answer 
HIV 1.08 .954 0 4 
Control .08 .277 0 1 
Continued incorrect 
strategy  
HIV 4.64 5.732 0 20 
Control 2.25 2.050 0 7 
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3.4.1 Overview: 
Descriptive statistics of the componential analysis are in table 12. As the control 
group scored significantly higher than the normative population it was noted that 
this should contrast sharply with the lower performance of the HIV group. 
Information pertaining to each code will be provided first, followed by control 
group performance, as this was gathered to create a benchmark of performance 
to which the HIV group could be compared.  
 
1. Rule detection 
The overarching theme ‘rule detection’ was based on three separate codes, rules 
acquired, sets acquired, and speed of acquisition. The Brixton requires detection 
of rules across 55 trials. There are six new rules to detect, two of which are 
repeated (one once, the other twice) to make up nine sets; therefore number 
achieved by participants was counted.  
 
Speed of rule acquisition across the test was measured through the total number 
of trials (errors) taken to acquire each rule across all nine sets. If people acquired 
the rule immediately after the pattern shifted no trials were added to the count. If 
no rules had been acquired the total number could reach 54. An average speed 
across tests (i.e. total number of trials to acquire rule divided by number of rules) 
was not used due to variance in number of trials per set (ranging from 3 - 8). 
 
All control group participants achieved the first rule and detected the majority of 
the 6 novel rules and 9 sets. These findings suggest excellent rule detection. 
Speed of acquisition was also quick as participants in the control group acquired 
the first rule in the first trial. As no other measure of this has been completed 
elsewhere, the number of trials taken to acquire all sets in this group was 
selected as the benchmark of ‘good’ within this study. 
 
All members of the HIV group also achieved the first rule in the first trial, 
suggesting good rule detection at the simplest level. Subsequently however, they 
detected fewer new and repeated rules than the control group and their detection 
was slower. Acquisition speed could also represent facility in switching set. 
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2. Shifting 
To achieve high marks in the Brixton, examinees must not only detect and follow 
rules but also shift (or switch) between new and old rules. Therefore the 
overarching theme of shifting was derived through the number of switches 
achieved across the test. 
 
The control group achieved near perfect shifting, suggesting no difficulties. The 
HIV group achieved fewer shifts suggesting lower switching ability, and also 
displayed increased variance across the group. For example, one participant in 
the HIV group did not manage any switches, instead utilising the first rule across 
the entire test even though the visual stimuli indicated change was needed.  
 
3. Set-loss 
Occasionally, participants suddenly gave an incorrect answer after having shown 
they had managed to acquire and follow the set’s rule. This was referred to as 
‘set-loss’ and was based on five related codes. Four of these related to qualitative 
aspects of set-loss and one to regaining set. Specifically, one code linked to a 
pattern of set-loss arising when the circle reached an extremity (i.e. named the ‘1-
10 shift’ by the researcher, see appendix T for an illustrated example). Another 
code linked to times when participants were shown the circle in position ten 
(following set 3) and would erroneously revert to the 10-5 rule (see appendix D). 
Furthermore, some participant’s pre-empted set-loss (coded as ‘anticipation’) by 
saying the rule was about to change and therefore they needed to change their 
answer. Other times ‘no obvious reason’ was noted, and was therefore coded as 
such.  
 
In the control group, participants lost at least one set. The pattern of set-loss 
errors from most common to least common was the ‘1-10 shift’, followed by 
‘anticipation’, ‘no obvious reason’, ‘reverting to the 10-5 rule’. This suggests set-
loss occurs within the ‘above-normal’ population, at least within this study. Most 
commonly this occurred due to erroneous attribution of certain numbers as 
indicators of pattern change and anticipation of rule change. When set-loss did 
occur, they regained set immediately approximately half the time.  
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Slightly fewer sets were lost within the HIV group than the control group. As they 
achieved fewer sets overall the mean score may not be directly comparable. The 
pattern of set-loss errors followed: ‘no obvious reason’, ‘1-10 shift’, then ’10-5 
rule’ and finally ‘anticipation’. The group also regained approximately half of all 
sets lost.  
 
In order to compare the groups more directly, and adjust for number of sets 
gained in total, the proportion of sets-lost of sets-gained were calculated (table 
13). Visual appraisal of the mean proportions indicate the HIV group lost a slightly 
higher percentage of acquired sets than the control group.  
 
 
Table 13. Proportion of sets gained that were subsequently lost  
 Group Mean SD Min Max 
Sets lost out 
of sets 
gained  
HIV .29 .291 .00 1.00 
Control .23 .115 .11 .55 
Note. Max score of 1 indicates a participant losing all sets of sets gained. 
 
 
Overall, it is hard to compare this section entirely. However, qualitatively it 
appears that set-loss may be normative, generally occurring through mechanisms 
other than spontaneously ‘falling-off’ task. In the HIV population spontaneous loss 
may explain set-loss slightly more frequently than in the control group.  
 
 
3.4.2 Reasons underlying errors 
In addition to ability to detect and switch rules, errors made by participants were 
explored and qualitatively interpreted. Error styles appeared to cluster under five 
main themes: ‘perseveration’, ‘reverting to a previous rule’, ‘the 1-10 shift’, 
‘response capture’ and ‘no observable strategy’. The Brixton total error score acts 
as the overall raw score, and the scaled scores based upon these numbers had 
already yielded a significant difference between these groups.  
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Error type 1. Perseveration 
Perseveration was noted across all participants, in the form of utilising and not 
shifting from the rule used in a just finished set (participants applied the rule to 
whichever position the circle had moved to, code 1), and repeating the answer 
previously given (code 2 for this theme). Number of total trials where 
perseveration of a rule could occur, could total up to 33 times (if a participant 
used the same rule all the way through, they would be wrong 33 times because 
set 1 rule reappears in sets 4 and 6), while perseverative answers could occur 54 
times. 
 
Perseveration with the rule just finished, and repeated answers, occurred within 
the control group at a very low level. In the HIV group perseveration was higher 
for both aspects.  
 
Error type 2. Reverting to a previous rule 
It was often noted that participants would trial a previous strategy while trying to 
identify the new rule or attempting a guess, leading this to become an 
overarching theme. If the rule was not acquired, participants might keep trialling 
that rule or another. Rules that participants’ trialled were most often the rules 
from set 1 (add one to the number on the page), 2 (remove one from the number 
on the page) and 3 (alternate between the numbers 5 and 10).  
 
In the control group, reverting to a previous rule made up the main error type. In 
the HIV group this occurred a similar number of times, but due to the group’s 
higher number of overall errors this did not constitute the majority of error types.   
 
Error type 3. 1-10 shift 
The ‘1-10 shift’ caused changes in patterns of guessing across both groups as 
mentioned in the section ‘set-loss’. This did not always cause people to lose set 
as it also occurred at times when the set had not been gained or was already 
lost. In the control group this error occurred slightly more than the HIV group. 
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Error type 4. Response capture 
This was the least noted error type and did not occur in the control group. In the 
HIV group four people said the number of the circle on the page rather than 
predicting the future trajectory of the circle (within sets where the circle was 
continuously moving and not static).  
 
Error type 5. No observable strategy 
Answers were coded together if they did not link to another response type or, in 
no perceptible way, the stimulus array. In the control group this occurred at a low 
rate. This was however, the main error type within the HIV group.  
 
 
3.4.3 Additional information about errors 
Another feature of responding occurred across this test. This linked to 
participants’ monitoring of the visual information presented. These were not 
included in the specific error types above as they were derived from 
consideration of patterns of responding. They were also considered to reflect an 
additional componential feature of executive functioning necessary for this task. 
 
Monitoring 
Monitoring comprised two codes. The first code described a pattern across tests 
that suggested participants had not noticed a rule change. This was deemed to 
occur when an individual’s response continued on from their previous answers 
and did not link to the stimulus array on the test. For example, on occasion 
participants following rule 1 (circle moves forward by one on each trial) would 
state the position of the circle as moving from position 1 to 2, then 3, 4, 5, 6 and 
7. Then as the set changed and rule 2 was required (circle moves backwards by 
one on each trial) the participant continued stating the circle will move to 8, then 9 
and so on. 
 
The second code linked to times when an incorrect strategy was repeated 
despite visual evidence that the strategy was not working. These two codes could 
have counted as perseveration but were located within monitoring as participants 
 65 
 
generally verbalised their surprise after they realised the rule had changed. They 
would not then self-correct previous errors but would instead shift to a new, more 
appropriate, strategy.  
 
Failure to monitor the stimulus array was low within the control group (only one 
participant failed to notice the rule shift - they self-corrected one trial later). 
Continuing with an incorrect strategy was slightly higher but still remained low. 
 
The HIV group appeared to have difficulties with monitoring the stimulus and their 
answers within the task. For example, except for one participant, all participants 
failed to notice the shift in pattern at least once. Continuing with an unsuccessful 
strategy also occurred more often in the HIV group than the control group.  
 
To summarise, multiple differences were noted between the groups suggesting 
that at the group level it was possible to identify components contributing to 
impaired performance in the HIV group, including slowed shifting, perseveration 
and reduced monitoring. 
 
 
3.5 Individual Profile Analyses of Brixton performance 
 
Individual case analysis, which allows exploration of within-group data, was used 
to identify whether a profile of deficits existed within the HIV group. Profile of 
performance for each participant was inspected and compared to the mean 
performance of the control group. Age and comorbidities were also considered 
when looking at profiles (see table 14). Bar charts for each participant are shown 
in figures 1-7.  
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Table 14. Age and comorbidities present in the HIV group 
Participant Age Comorbidity 
1 38 Treated TB. 
Depression treated with antidepressants. 
2 46 None. 
3 50 Treated TB. 
Depression treated with antidepressants. 
4 58 Treated Syphilis. 
5 65 Treated Syphilis. 
6 49 NSTEMI. 
G6PD. 
7 65 COPD. 
Kaposi’s Sarcoma. 
8 49 Treated C-Diff 
9 56 None. 
10 40 History of substance misuse. 
11 61 HIV encephalopathy. 
12 47 Back pain. 
Treated stomach ulcer. 
13 44 Leg pain. 
Treated toxoplasmosis. 
History of substance misuse. 
Depression treated with antidepressants. 
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Figure 1. Counts for the control group (mean) and HIV participants 1 - 2  
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Figure 2. Counts for the control group (mean) and HIV participants 3 - 4 
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Figure 3. Counts for the control group (mean) and HIV participants 5 - 6   
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Figure 4. Counts for the control group (mean) and HIV participants 7 - 8   
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Figure 5. Counts for the control group (mean) and HIV participants 9 - 10   
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Figure 6. Counts for the control group (mean) and HIV participants 11 - 12   
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Figure 7. Counts for the control group (mean) and HIV participant 13   
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Inspection of individual profiles highlighted the variance in performance across 
the group. Participants 5 and 6 did not complete the task. The charts illustrate the 
number of sets they acquired of the proportion they managed. All other 
participants’ data were completed. Despite the heterogeneity of counts and 
profiles, there were general themes across the participants’ performance. The 
graphs indicate that: 
 
1. Except for participant 13, the HIV group gained fewer rules and sets than the 
control group (mean). Participants 7, 10 and 11 performed close to the control 
group (mean) gaining one less rule and set. All other participants performed 
below this level. 
 
1a. All participants took more trials to acquire rules than the control group 
(mean), suggesting slowed speed. 
 
2. Except for participant 13, the HIV group all managed fewer shifts than the 
control group (mean). Participants 7, 10 and 11 were again closer to the control 
group (mean), managing one less switch than them. All others performed below 
that number.  
 
3. No distinct pattern exists for set-loss since a wide level of variance was seen in 
participant profiles:  
 
3a. Not all participants lost set in the HIV group, it occurred in 8 cases. There was 
no specific profile of loss consistent across all losing set. However, sets were 
mostly lost due to no observable reason and then the 1-10 shift, resembling the 
pattern found at the group level. Interestingly, those performing closer to the 
control group (participants 7, 10, 11, 13) lost at least 2 sets. Those who did not 
lose a set generally had an overall profile of impaired performance, for example 
in rules and sets acquired, and shifts attained (e.g. Participants 3 and 9).  
 
3b. There did not appear to be a profile linked to regaining set. However, apart 
from participant 10, all participants who lost set regained at least one 
immediately.  
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4. Number of errors made was consistently higher in HIV individual profiles than 
the control group (mean), suggesting lower performance across the board. 
However the following was noted: 
 
4a. Perseverating with a previous rule happened at least once across all 
participants apart from participants 4, 9 and 12 (whose profiles were 
predominantly made up of no observable strategy error types). However this did 
not always occur above the control group (mean).  
 
4b. Except for participant 9, perseverating with a previous answer occurred in all 
individual profiles. Except for participants 3 and 7 (who had the same count as 
the control group) this occurred more frequently than the control group (mean). 
 
Reverting to a previous rule, which occurred in all participants except participant 
3, was consistently noted across the group, however, this was not always higher 
than the control group (mean). 
 
4c. The 1-10 shift only caused errors in participants 1, 2, 4 and 13.  
 
4d. Response capture only occurred in participants 1, 2 and 8.  
 
4e. Except participant 3, who utilised the same rule throughout, errors with no 
observable strategy were consistently counted across all profiles more times in 
HIV participants than the control group (mean). 
 
5. Aspects of performance linked to monitoring were common within the HIV 
group: 
 
Except for participants 7 and 13, all had at least one trial where they had missed 
a rule change. HIV participants did not have consistently higher counts than the 
control (mean). However, within the control group only one participant had 
performed this kind of error, while in the HIV group this was noted in almost every 
individual profile.  
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Continuing with an incorrect strategy was not a consistent profile across the HIV 
group, however when it did occur the count was consistently higher than the 
control group (participants 1, 2, 4, 9, 10, 12). 
 
In summary, there was not a distinct profile (observable when viewing individual 
summaries) that was consistent across all variables. However, some 
performance styles were consistent and seen across the group even when 
participants performance was less impaired.   
 
With regard to age and comorbidity, no relationship was seen between either 
variable and performance profile. Two examples of this include: 1) participant 13 
(who performed closest to the norm) presented with four comorbidities, and was 
47 (near the mean age of the group); 2) Participant 11 who also performed close 
to the norm had one comorbidity but was 61 (the older end of the age range).  
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4 DISCUSSION 
 
 
A plethora of evidence exists documenting executive dysfunction within HIV-
positive populations diagnosed with HAND. Little exists, however, looking at the 
componential processes underpinning these deficits. This study aimed to address 
this research gap. Specifically, it aimed to investigate an aspect of executive 
functioning known as induction, or multiple trial concept formation; to assess 
whether it is impaired in HAND and furthermore, what mechanisms if any are 
responsible for decreased performance. This required quantitative and qualitative 
analyses of a well-known test of induction, and therefore production of a novel 
scoring system. Findings and their implications will be discussed within this 
chapter.  
 
 
4.1 Summary of results 
 
4.1.1 Participant related variables 
Two groups of participants were recruited to this study, to create comparable 
subsets of individuals on tests of induction. The groups were well matched on 
demographic variables (age, gender, number of years in education and reading 
ability). Participants’ age ranges and gender ratio mean the study’s findings 
describe and relate most closely to cohorts of PLWH who are male and in the 
middle age ranges. Apart from gender, the other demographic factors controlled 
for in this study are known to contribute to neuropsychological test performance 
which suggests they should not be responsible for between group differences. 
Despite this, the control group, while not reliably different from the patient 
sample, showed a trend towards increased ability as measured by the WTAR.  
 
Furthermore, in the HIV group there was an increased number of people not 
educated within the UK, or not brought up with English as first language 
(language was not reliably different across groups). Performance on the Word 
Context Test differed by primary language, suggesting these results need 
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cautious interpretation. This was not the case for the WTAR however, suggesting 
language was not responsible for differences seen. Therefore, exactly matched 
years of education but slightly differing reading ability may instead support the 
notion that years of education do not describe quality of teaching, making it a less 
accurate predictor of subsequent learning and ability (Manly et al., 2002). 
Alternatively, it could suggest that reading measures present terminology not 
relevant to people born outside of the culture in which it was developed. Finally, 
premorbid tests work on the notion that reading ability remains relatively spared 
during neurodegeneration. If reading ability was impaired in this group, premorbid 
functioning will not have been accurately represented in this study.  
 
The HIV group 
Viral load counts within the HIV group suggest a mix of illness severity within 
patients, however CD4 counts suggest high levels of immunosuppression and 
illness. For example, seven people would have met criteria for AIDS-defining 
illness (<200 CD4 cells per cubic millimetre of blood; Castro et al., 1993). Two 
patients were on the cusp of this (at 200) and all others clustered near this mark. 
The discrepancy between viral load and CD4 count suggests those with low viral 
load and low CD4 count (n=3) had been successfully treated at the viral level, but 
their CD4 had yet to replenish its numbers. This would indicate they were 
recovering. Therefore these findings will best illustrate performance of those 
considered medically unwell rather than those considered well with good viral 
load and CD4 count. Relationship between performance and illness related 
variables were not assessed, as counts were collected at varying distances from 
the testing day, suggesting they could be best used as rough guides to illness 
status rather than reliable variables.  
 
Comorbidities were present in all patients except two within the group. While 
three were receiving treatment for low mood, two different participants were 
suggested to have high levels of anxiety and depression as measured by the 
HADS. These comorbidities should be considered when interpreting the reliability 
the findings.  
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General cognitive functioning within the HIV group was found to be impaired in all 
areas assessed within this study apart from visuospatial functioning. Impairments 
noted were distributed across the population in a way that differed from the 
normative population, suggesting impairments generalized across the group. 
These findings conform to literature indicating relative sparing of the visuospatial 
domain and related lobes in HAND (e.g. Heaton et al., 1995). It also suggests the 
sample are representative in terms of the population we hoped to assess. 
Patients were not further categorised into stage of HAND, in part due to the 
exploratory nature of the study but also due to the contentious nature of the 
categories. 
 
 
4.2 Question 1. Is induction disrupted in HAND when compared to a non-
clinical population? 
 
4.2.1 Induction in the HIV group compared to normative data 
Measures of concept formation, both single trial (Similarities and Matrices 
Reasoning) and multiple trial (Brixton and Word Context Test), were also 
impaired compared to normative populations in terms of average scores and the 
distribution of performance across the group. Induction requires attention and 
information processing, short-term memory storage and abstract reasoning. 
These abilities when assessed in the general battery were all reliably impaired 
however, single trial concept formation and visuospatial memory (spatial span) 
were relatively preserved when comparing performance to normative scores. 
When comparing distribution of performance in the HIV group to normative 
distributions, single trial concept formation remained relatively spared. Brixton 
performance was also relatively spared but to a lesser extent (visual multiple trial 
concept formation).  
 
Multiple regression found there was no predictive value of visuospatial 
perception, working memory or verbal concept formation on Brixton performance. 
This suggests Brixton test scores reflect the Brixton’s test properties alone. Lack 
of relationship between the Word Context Test and the Brixton is surprising, as 
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their shared assessment of multiple trial concept formation is not reflected in this 
result. This could mean Brixton performance was not due to participant’s 
inductive ability. Alternatively, it could reflect the different qualities of the tests 
linked to language, cultural specificity, or another component suggesting the tests 
are philosophically linked but not reliably associated. 
 
Overall, this data suggests that induction is affected in HAND and is not solely 
due to general impairment in functions known to contribute to induction. It does 
not suggest it is the most affected function however. It also indicates that concept 
formation is still possible within the group particularly when single instances are 
necessary to abstract relationships in information (i.e. all information needed to 
infer relationships is provided at one time). Visuospatial sparing in terms of 
perception may suggest induction would improve when linked to visuospatial 
information. However, the different tests of single trial concept formation did not 
illustrate this, with improved performance noted on the verbal test (Similarities) 
over visual (Matrices Reasoning).  
 
 
4.2.2 Induction in the non-clinical population 
In order obtain a matched sample, a cross-section of individuals were recruited to 
the control group. Overall their years in education and reading ability suggests 
the group represented a wide variety of people (i.e. with limited to high levels of 
education), akin to experience within the patient group, with their mean abilities 
falling within the average range. It was hoped they would represent an average to 
which the HIV group could be compared.  
 
Only multiple trial concept formation was assessed within the control group. 
Following the model of inductive processes discussed in the introduction, which 
describes the necessary gathering of instances for real world inductive 
processes, multiple trial tests may more closely represent functional induction. 
This suggests it was acceptable to neglect single trial tests within this group.  
Verbal induction (Word Context Test) was within normal range in the control 
group, however visuospatial induction as tested by the Brixton was not. The 
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group instead performed above the norm on this test. Without further cognitive 
assessment of controls it is not clear what specific features led to this above-
normal finding. Whatever the reason this was an unexpected finding and will 
have affected results.   
 
 
4.2.3 Induction in HAND compared to a non-clinical population  
The HIV group performed significantly below the non-clinical population on both 
tests of induction. This was not unexpected, as they had already been shown to 
perform below the normative average, while the control group performed at the 
norm on the Word Context Test and above the norm on the Brixton. Not all 
participants within the HIV group completed the Brixton, but adjustment for 
number of trials completed, and inclusion of the missing people, did not alter 
these findings. Within group, both the HIV-positive and control population 
performed less well on the verbal Word Contest Test than the visual Brixton. This 
may suggest a pattern of inductive strengths that was similar across groups, or 
may reflect divergent aspects of the tests used to quantify inductive ability, plus 
the primary language makeup of the groups. 
 
The Word Context Test requires literacy, an understanding of the words used 
within the test and an intact verbal domain. It is also culturally specific. The first 
trial presented to participants, which comprises a practice run, has a final 
statement “a sev a day keeps the doctor away”. As the final clue sentence (of this 
trial) it is meant to be the most persuasive. Across both groups, some participants 
did not know this British proverb. This example will not have affected findings as 
it is not scored, however other trials may be considered similarly culturally 
specific.  
 
The Brixton is meant to be less vulnerable to culture and literate abilities, 
implicating itself as a purer measure. Therefore cultural features of the Word 
Context Test may have led to both groups’ weaker performance on this test. This 
is illustrated by the finding that primary language and performance on this task 
were linked.  
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In summary, these findings indicate that both simple (single trial) and more 
complex (multiple trial) induction is impaired in a HAND population when 
compared to a non-clinical population and published normative data. However, 
participant variables such as primary language may have added to these 
findings.  
 
 
4.3 Answering questions 2 and 3 
 
To assess induction more intricately, another scoring system had to be devised 
that had a baseline measure upon which the HIV group could be compared.  
 
 
4.3.1 A novel scoring system for the Brixton  
The scoring system was derived through componential analysis, combined 
hypotheses about induction from previous systems (e.g. Burgess & Shallice, 
1996; Heaton et al., 1993) and related literature. Additional themes arising in the 
performance styles and errors of the participants recruited were also added. The 
final measure did not map directly onto previous systems or known components 
of induction. For example, a measure of memory may have been expected, as it 
is known to underpin induction. However no discernible measure was found, and 
therefore no related code. Additionally, as previously stated error types described 
as bizarre, or due to misapplication of strategy (Burgess & Shallice, 1996) were 
not included in the final system. 
 
The final system identified quantifiable components of the Brixton, such as ability 
to detect rules, speed, shifting, maintaining set and monitoring. Furthermore, 
errors (considered operationalisations of underlying components of the inductive 
process) were observed to fall into categories relating to perseveration, reverting 
to a previous rule, 1-10 shift, response capture and no observable strategy. The 
initial components (except speed) plus the error types, perseveration and 
response capture, directly map onto executive functions. That is, if you follow the 
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hypothesis that executive functions aim to help an individual identify and act 
towards a pre-defined goal. Moreover, aside from acquisition of the first rule 
within the test, all other components could be said to link to executive functions 
not directly considered as induction, linking instead to other functions necessary 
for ongoing induction in tests such as the Brixton. For example, the number of 
rules and sets detected, as well as the speed of acquisition, involve switching and 
ongoing attention.  
 
This scoring system is idiosyncratically linked to this study. Two particular codes 
illustrate this point:  
 
    Anticipation: People failed to maintain set for multiple reasons. The code 
‘anticipation’ linked to participant’s comments preceding behaviour 
change. This study did not ask participants to describe their strategies 
aloud, however people invariably did so. The qualitative nature of the 
study allowed documentation of verbalised behaviour, gaining deeper 
insight into examinees actions, but only during times of their choosing. 
This will have affected findings as those not speaking may have been 
marked differently. With this in mind, a think-aloud protocol (e.g. Davison, 
Vogel & Coffman, 1997) would have been well placed within this study to 
more clearly explain participant’s performance.  
 Response Capture: People within the HIV group were noted on occasion 
to respond with the number on the page rather than a number linked to the 
circle’s trajectory. The control group did not err in this way, suggesting it as 
a phenomenon linked to this population.  
 
Subsequently, it is not possible to say whether another population would have led 
to an alternative system, or whether another researcher would have reached a 
different conclusion. Some writers on qualitative analysis suggest that findings 
can only ever be linked to the context of the time in which, and the researcher by 
whom, they are created (Willig, 2013). They may also say this can be acceptable 
as long as it is acknowledged. Other qualitative researchers would disagree, 
stating that objectivity needs to be the aim from the outset, (e.g. through 
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triangulation or inter-raters; Denzin, 1970). Something akin to triangulation could 
be described here as multiple data sources were consulted prior to testing, to 
elucidate underpinning factors in induction. Irrespective of this, qualitative 
research is often used to identify information upon which subsequent larger 
studies and scales can be based (Curry, Nembhard & Bradley, 2009). Therefore, 
the inevitable subjectivity of qualitative research does not have to be considered 
problematic at this stage.  
 
Another important reason for cautious interpretation is that, like the Brixton test 
itself, this scoring system has no related stratification to adjust for age related 
performance. The groups were well matched in terms of age, which goes some 
way to addressing this issue.  
 
 
4.3.2 Non-clinical performance as measured by the scoring system 
The control group was assessed to gain a baseline level of functioning, and 
hopefully provides an initial illustration of ‘normative’ performance styles. 
 
Findings linked to this method of componential analysis suggest that high-level 
performance on the Brixton requires good concept formation, high speed 
detection and good switching abilities. The control group were considered to have 
both of these requirements due to the number of sets gained and the trials it took 
to gain them. Classification of performance as ‘good’ on components such as 
speed of acquisition was made post-hoc through comparison with HIV group 
scores, as no previous benchmark existed for these categories. Maintaining set is 
also required to achieve high marks within the test (as any other kind of 
performance increases error scores), however, all control group participants lost 
at least one set. This could indicate that set-loss is a normative phenomenon 
occurring within high scoring individuals with reasons linking more to erroneous 
attribution of specific items as predictors of pattern change than to spontaneous 
loss. Regaining set occurred approximately 50% of the time, equalling the 
benchmark set by this group as the norm in a non-clinical population.  
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The number of errors made on the Brixton inversely correlates with overall 
performance. In line with this the control group made low numbers of errors as 
compared to normative data, however multiple error types were made which 
suggests various kinds of inaccuracies are possible within induction and the 
Brixton. Reverting to a previous rule was the most common error type, followed 
by (to a lesser extent) continuing with the rule just finished, no observable 
strategy, misinterpreting the 1-10 shift and finally, perseverating with a previous 
answer. The number of trials across which these errors were made suggested 
good rule detection and following, with low levels of perseveration within the 
group.  
 
Reusing a previous rule was the most common error response within the control 
group. This may suggest that reverting to a previous rule is a common strategy 
through which guesses at a new rule can be made when not enough instances 
have yet been acquired by the participant. During initial analysis there was a 
feeling that some guesses provided by participants were ‘educated’ and based on 
a reasonable, yet incorrect strategy. A code such as this required more tenuous 
interpretation than fitted the analysis. Potentially, trialling a previous rule for the 
first trial of a new set could represent this kind of strategy. In the WCST, Barceló 
(1999) found that ‘normal’ participants undertake trial and error processes to 
speed up rule detection. Barceló and Knight (2002) call these ‘efficient errors’ as 
they utilize recent contextual information to optimize set-shifting. This could be 
reflected in the performance documented here. 
 
Furthermore, the group showed the importance of continuous monitoring of the 
stimulus array and their own performance. Ongoing monitoring was considered to 
be good in the control group as participants were rarely observed to miss a rule 
change (only one participant did this) or continue with an inappropriate rule, and 
self-corrected quickly when they noticed they had made an error. Again, 
categorization of an ability being ‘good’ (i.e. when linked to continuing with an 
incorrect rule) was labelled through their overall performance as ‘above average’ 
and their subsequent comparison to HIV group performance. 
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4.4 Question 2. If induction is affected, is there a profile of disruption on 
measures of induction in HAND or does it differ by person?  
 
4.4.1 Profile of induction at the group level 
Quantitative analysis of performance at the group level indicated that HIV 
participants showed impaired performance on the Brixton, suggesting impaired 
rule detection. However, when looking at performance at the componential level, 
all participants achieved the first rule, suggesting simple rule detection was 
relatively intact. Problems arose when individuals were expected to detect and 
change to further rules. Cognitive inflexibility may have attributed to this, as lower 
levels of rules were acquired post-first set, and less shifts were achieved than the 
control group. In terms of error types, perseveration was high, suggesting that 
people became stuck within set. When shifting and looking for new rules, the HIV 
group trialled previous rules in the same manner as the control group but gave 
much higher numbers of no observable strategy and perseverative answers.  
 
Interestingly, the HIV group were less likely to monitor rule changes or their 
progress, leading to increased use of ineffective strategies. This suggests that 
simple rule detection is relatively spared (as backed by performance on single 
trial concept formation) at the group level. Problems occur when cognitive load is 
increased and the participant has to switch repeatedly. Failure in cognitive 
flexibility (shifting and perseveration), and self and environmental monitoring 
appear to be underpinning the majority of difficulties. Furthermore, the high 
number of no observable strategy errors suggests a facet of performance not yet 
understood. 
 
 
4.4.2 Individual performance in the HIV group 
Individual case analysis showed higher variance among the HIV-positive 
participants with some performing closer to the control group and others 
demonstrating more impairment. To measure this, individual profiles were 
compared to the control group mean for each component. Not all people in the 
control group will have performed equal to or better than the mean, but those 
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performing differently to the mean within the HIV group were defined accordingly 
(as better or worse than that number). Therefore, again, findings are tentative. To 
answer question 2, profiles will be discussed without detailed reference to 
mechanisms, as this pertains more to question 3.   
 
Across the group, no consistent overall profile existed for all measured variables. 
No relationship was noted between age, comorbidity and performance profile 
either. However, two sub-profiles were noted in performance that linked to level 
of impairment (measured by overall performance on the Brixton). The first was 
noted across all participants including those performing closest to the non-clinical 
population (participants 7, 10, 11 and 13) and is therefore suggested to present a 
sub-profile of mechanisms impaired in HAND at the earlier stages of (inductive) 
dysfunction. This profile linked to consistently higher numbers (when compared to 
the control group mean) of: 
 
1. Trials to acquire rules and sets2 
2. Errors  
3. No observable strategy error types 
4. Perseverating with the previous answer 
 
This suggests an early profile of impairment in HAND linked to speed of rule 
acquisition, and general and specific error types. As impairment in performance 
increased (as measured by overall score) there was another pattern relating 
performances to each other. This indicated lower:  
 
5. Numbers of rules and sets acquired 
6. Numbers of shifts achieved 
7. Times they did not notice a rule or set change 
 
This suggests that as impairment increases other components become disrupted, 
                                            
2 Number of rules and sets acquired were deemed not to be part of this initial profile, as 
participants 7, 10 and 11 scored so close to the control group mean. 
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further impairing inductive performance on the Brixton. These link to rule 
detection over time, shifting to a new rule or answer, and monitoring. These 
seven factors could act as a core profile of impairment in induction in HAND, 
which changes over time. However, other variables were seen (but not 
consistently) at the individual level such as response capture, and other types of 
set-loss and errors. Variability within the group suggests that each person may 
have their own idiosyncratic profile in addition to the profile mentioned here.  
 
 
4.5 Question 3. What underlying mechanisms do these deficits on 
measures of induction reflect? 
 
At the group level, mechanisms underpinning HAND were more clearly 
interpretable as they generalized across the group and linked to decreased 
performance in the majority of sections measured by the new system. The 
individual performance instead elucidated themes with individuals also showing 
their own profiles. Therefore mechanisms will first be discussed in terms of those 
seen across the group, then individually.  
 
 
4.5.1 Mechanisms underpinning early impairment in induction 
 
Simple rule detection – a spared mechanism 
All HIV-positive participants gained the first rule of the Brixton within the first trial, 
suggesting that rule detection at its simplest does not underpin impaired 
performance on induction. This finding is tentative as a methodological issue with 
the Brixton test’s practice section was noted during testing. Prior to initiation of 
the scored test, three pages are used to illustrate the test. These pages show the 
circle moving around following a ‘plus one’ rule (the circle moves forward one 
position every time the page turns), the same rule utilized in the first testable set 
of the Brixton. This may have confounded performance as people had been given 
chance to practice and identify this rule, which they subsequently applied when 
the test started. This hypothesis was evidenced as the first trial, which should be 
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a complete guess, was completed 100% accurately across all participants 
(irrespective of group). An alternative example pattern should be considered in 
future tests of the Brixton, and would be better used to validate the findings of this 
study.  
 
Speed of rule acquisition 
All HIV-positive participants were slower to acquire sets and rules, even those 
who managed to gain a (near) complete set. This could suggest underlying 
mechanisms of impairment linked to declined inductive processes. For example, 
that effective induction in HAND needs more trials for information to be gathered, 
stored and integrated. The cognitive component most closely related to this is 
information processing.  
 
HAND is considered to be primarily subcortical, suggesting early impairment of 
information processing and attention. Slowed information processing has been 
suggested by Hardy and Hinkin (2002) to be the cardinal feature of HAND, and 
has been repeatedly demonstrated in tasks with and without motor demands 
(Woods et al., 2009). Becker and Salthouse (1999) suggest slowed processing 
may underpin neurocognitive abilities (in HAND) on tasks not expressly noted as 
‘speeded’. The findings within this study may reflect this literature, as induction 
and the Brixton task would not primarily be considered to have a speed-based 
component.  
 
Information processing has been shown to decrease further in HAND when 
cognitive demand of a task increases, particularly when attention is divided 
(Martin et al., 1999). The Brixton requires high cognitive demand and controlled 
attention for set-shifting, suggesting information processing may indeed have 
been by slowed by task demand. In general, shifting ability will have affected the 
speed with which rules were acquired, making it difficult to extrapolate these two 
different components.  
 
Errors 
HIV-positive participants made more errors in general, with particular reference to 
errors with no observable underpinning strategy and perseveration. Increased 
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errors within the Brixton are traditionally associated with impaired induction. 
However, the scoring system devised within this study suggests error level may 
not solely link to induction. It is not possible to interpret the increased number of 
errors at the general level at this point, therefore more focus is given to the error 
type.  
 
No observable strategy error type 
Multiple factors need to be considered when interpreting the mechanisms 
underpinning the no observable strategy error type. Burgess and Shallice (1996) 
referred to errors like this as bizarre, as they “appear to arise from a preference 
which is not based on a rational response to the current task situation” (p. 253). 
They then link bizarre errors to the ‘guessing behaviours’ observed in another 
study (Miller, 1985) looking at cognitive risk-taking in anterior lesion patients. 
Guessing behaviour in that study was interpreted as impulsivity (Miller, 1985; 
Miller and Milner, 1985), an inability to prevent expression of the first answer to 
come to mind. Burgess and Shallice might subsequently name impulsivity as one 
of the mechanisms underpinning impaired performance in HAND.  
 
However, lack of an observable strategy does not directly imply a bizarre answer 
or lack of rationale. For example, Nelson (1976) noted in the modified WCST that 
errors occurring in those considered ‘above-normal’ in intellect, which seem 
unusual, sometimes reflect elaborate strategies unobservable to the viewer. 
Therefore it is possible the group utilised reasonable strategies unknown to us. 
Conversely, this error type could reflect a lack of strategy (problem solving 
difficulties) within the group. Arentoft and colleagues (2013) defined impaired 
strategy development as the underpinning mechanism of ‘risky’ decision-making 
within HAND. Similarly, Cattie and colleagues (2012) linked decreased efficiency 
and accuracy in problem solving to planning difficulties in HAND. Further 
investigation, using a think-aloud protocol for example, would be required to 
elucidate which, if any, of the above mechanisms led to the increased level of this 
error type.  
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Perseveration 
Perseveration was made up of two separate codes. HIV-positive participants 
showed a pattern of perseveration linked to one (repeated answers) but not the 
other (perseverating with a just finished rule). This suggests a discrepancy in the 
kinds of perseveration documented here.  
 
Lezak and colleagues (2012) suggest two kinds of perseveration exist, which 
must be differentiated in order to understand the causal mechanism. The first 
type links to responses that continue with a previous strategy, reflecting an 
inability to terminate in-use strategies and shift to new ones, this directly links to 
cognitive inflexibility (Goldberg, 1986). The other error type links to repetition of a 
previous answer due to a lapse in attention and/or working memory. This lapse 
renders the person temporarily unable to move forward as they have lost the 
information driving their next step. It is possible Lezak’s account describes the 
two kinds of perseverative responses noted within this study, with rule 
continuation reflecting cognitive rigidity, and answer repetition indicating 
attentional and memory based deficits.  
 
The mechanisms underpinning the initial profile of impairment in HAND, linked to 
the Brixton, therefore probably links to lapses in attention (considered the 
hallmark of HAND; Morgan, Woods, Delano-Wood, Bondi & Grant, 2011) and 
working memory (both verbal and visual working memory are shown to be 
impaired in HAND; Martin et al., 1995, 2001). This reiterates Johal’s (2014) 
suggestion that these may be two mitigating factors in inductive performance in 
HAND. However, perseveration linked to cognitive flexibility should also be 
considered when working with people clinically, as this also occurred within the 
group but did not constitute a consistent profile.  
 
 
5.4.2 Mechanisms underpinning impairment in HAND as impairment progresses 
 
Rule and set detection after first rule achieved 
As overall performance scores decreased, participants acquired fewer total rules 
and sets than the control group. This could suggest impaired induction, although 
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rule detection at its simplest seemed intact. Interestingly, the most commonly 
acquired rules were those most closely relating to the first rule. For example, rule 
one sees the circle move forward one position every time the page turns. Rule 
two then sees the circle move backwards one position with each trial. These two 
were most commonly achieved. Sets four, five and six are repetitions of these 
rules. Then the rule in set nine switches between these rules. Again this was 
achieved slightly more often. Rules from sets three (the circle moves between 
position 10 and 5), seven (the circle moves between positions 10 and 4) and 
eight (the circle stays at position 9), those most different to the previously 
mentioned rules, were most often missed by the HIV-positive participants. This 
could suggest induction becomes less accomplished when rules become more 
abstract or differ substantially from the first acquired pattern. Moreover, 
decreased set detection may link to other components including cognitive 
flexibility.  
  
Shifting sets  
Within the HIV group those achieving comparatively lower scores also shifted 
between rules a lower number of times. This suggests lower cognitive flexibility 
may play a part in poorer performance as impairment increases. HIV-positive 
participants performed in the impaired range on both the switching 
subcomponents of verbal fluency verifying the suggestion that this is impaired 
within the group. At its most extreme, cognitive rigidity causes people to become 
stuck within one mode of functioning, as observed in the performance of 
participant 3 who utilized the first rule throughout the test.  
 
This finding is not unusual as HIV is known to affect cognitive flexibility (e.g. 
Iudicello et al., 2013; Giesbrecht et al., 2014), and has been found to be the 
highest predictor and clinical indicator of poor performance on other tasks of 
executive functions, such as when using a gambling task to assess decision-
making (Carter et al., 2003). Surprisingly, cognitive flexibility has not been found 
to reliably associate with real-life functional performance linked to decision-
making (Iudicello et al., 2013). This may suggest that a test of real-life functioning 
in situations involving induction, not just neuropsychological batteries, could add 
another dimension to this study. For example, component counts linked to 
 93 
 
induction could be correlated with aspects of the Árnadóttir OT-ADL 
Neurobehavioural Evaluation (A-ONE; Árnadóttir, 1990), to identify which aspects 
most closely link to lived experiences. 
 
Monitoring 
Within the HIV group, not noticing a rule change was more consistent than the 
monitoring code linked to utilizing an inappropriate strategy, and appeared to be 
part of a profile of impairment seen as Brixton-related performance decreased. 
This performance style was considered to reflect an inefficiency in continuous 
monitoring of, and responding to, the stimulus array. The concepts most closely 
linked to this in the neuropsychological literature are self-monitoring and 
metacognition.  
 
Self-monitoring is integral to daily functioning, as the ability to perform a task is 
only as effective as an individual’s ability to monitor and correct their performance 
(Lezak et al., 2012). Monitoring is linked to the integrity of prefrontal structures 
(Fleming, Huijgen and Dolan, 2012), damage to which has been shown to lead to 
two categories of deficits: those who do not perceive errors and therefore do not 
self-correct, and those who perceive the error but do nothing to correct it (known 
as pathological inertia; Lezak et al., 2012). The former concept may relate more 
to processes witnessed within this study as the HIV group changed behaviour 
once they perceived the rule change. 
 
Metacognition, which links to the ability to think about thinking and have insight 
into oneself, overlaps with the idea of self-monitoring. The finding that 
approximately 50% of people with HIV lack insight into their cognitive difficulties 
(Weber et al., 2009) is thought to indicate metacognitive impairment in HAND. 
Therefore, this finding does not propose a new feature of HAND but suggests 
metacognitive and self-monitoring dysfunction may underpin poorer inductive 
performance. 
 
Overall  
To summarise, it appears that rule detection in its simplest form is spared. 
However across people with HAND, mechanisms such as slowed information 
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processing may slow the time it takes to induce rules, and lapses in attention and 
working memory may cause people to repeat previous answers. Furthermore, 
error types at this earlier stage suggest individuals may be impulsive, lack 
strategy or simply did not explain their performance. Once impairment increases, 
rule detection may become poorer and this could be caused by decreased 
cognitive flexibility, or error perception and monitoring.  
 
 
4.5.2 Other mechanisms 
At the individual level other components were noted to affect induction, 
dependent on the participant, for example, set-loss varied across participants. 
Moreover, when impairment as measured by Brixton performance was high, set-
loss was low. Failure to maintain set has been described as an inability to 
perseverate. It can occur due to distractibility (disturbance by an external stimuli) 
or an internal process reflecting difficulty with self-control (Lezak et al., 2012). 
The latter point, also known as cognitive impersistence, occurs when an 
individual’s focus has already moved to another area, or when they have lost 
interest, slowed down or given up. Set-loss occurred within each group, 
highlighting that it is not a pathological process by itself. However, it is interesting 
that it occurred less with poorer performance. This could be due to the lower 
number of sets acquired and therefore lost, or could reflect perseverative ability; 
a level of cognitive rigidity stopping people spontaneously losing set.  
 
People lost set for multiple reasons within both groups. When occurring due to 
anticipation or another reason it may not link to an impaired mechanism, but to 
incorrectly interpreted visual signals. When occurring due to no observable 
reason, this could reflect higher levels of cognitive impersistence linked to 
attentional control, fatigue or boredom. Recruiting from an unwell population 
means fatigue is not improbable, especially as the Brixton was one of the later 
tests of a long battery. Furthermore, while neuropsychological literature does not 
generally explore the link between set-loss and (working) memory, it would make 
sense that those unable to hold information in mind whilst performing a task may, 
on occasion, lose set as they suddenly find themselves lost within the task at 
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hand. Each of these explanations could account for the kinds of set-loss seen in 
this study. Again, it would require a think-aloud protocol to accurately depict the 
real mechanisms underlying performance. 
 
Response capture was another mechanism noted in some members of the 
sample. This kind of response suggests a failure in the executive functions 
necessary to keep you on task (Humphreys & Riddoch, 2000). It is similar to 
utilisation behaviour, a term used by Lhermitte (1983) to describe times when 
items and objects within the world captures an individual’s attention causing them 
to act upon it despite other information suggesting this is not what is required. 
 
 
4.6 Clinical Implications 
 
To the authors knowledge this was the first study to directly investigate induction 
within HAND, and therefore also addresses feasibility of use of the Brixton within 
the HIV-positive population. Additionally, it was the first to explore the 
mechanisms underlying induction within this population. A number of implications 
are therefore discussed below. 
 
1. It is possible to derive a componential scoring system for the Brixton  
Findings within this study are tentative, and need replicating in order to assess 
the reliability and validity of the scoring system created here. However, it has 
shown the complexity of skills required for one test of executive function, and 
therefore, the lack of information gained from direct interpretation of single score 
measures of functioning (e.g. the Brixton). With this in mind, this study has shown 
it is possible to derive a componential scoring system for the Brixton, similar to 
that utilised in other tests such as the WCST. It has also shown that with this 
technique, consistent and meaningful data can be gathered explaining 
performance. 
 
2. It is necessary to use componential scoring systems when working with HAND 
An overall profile of HIV-related impairment linked to induction did not emerge. 
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Instead, themes arose that were also accompanied by other idiosyncratic 
difficulties. This serves to reiterate the need for componential analysis when 
utilising the Brixton. Therefore, clinicians should focus on creating, validating 
and/or utilizing a system such as the one devised in this study to understand the 
specific features of the clients seen.  
 
3. Outcomes of componential analysis are needed to identify specific treatment 
targets 
Induction is an important ability that is required for people to function 
independently within their environment. When induction breaks down people will 
become concrete, struggling to interpret patterns and rules within the 
environment and generalize them to other areas, or follow them without didactic 
teaching. Therefore, findings suggest this could occur within the population of 
people living with HAND, having significant implications for people’s 
independence, especially at later stages. Moreover, the current study highlighted 
that induction of rules is not by itself problematic, but is further affected by a 
number of other skills.  
 
Treatment should be based on the outcome of componential assessment. For 
example, building upon on the findings of this study people may need help at the 
early stages with:  
 
  slowed information processing, through strategies such as increased time, 
repetition and chunking of information, increasing an individual’s chance 
to take on information. InSight (Posit Science, 2012), a computerized 
training program aimed at improving processing speed could also be 
used. 
  should errors with no observable strategy link to inhibition or problem 
solving deficits, structured environments should be used to support 
individuals. Breaking problems into manageable chunks, sequencing, 
routines, prompt and cues for behavioural organization should also be 
implemented. 
  lapses in attention and working memory should be supported through 
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chunking tasks, use of cueing reminders, self-checking strategies and 
awareness of deficit training (e.g. through Sohlberg and Mateer’s three 
stage approach; 1989)  
 
As HAND progresses they may need help with: 
 
 cognitive flexibility through behavioural support outlined above and 
selection of an appropriate care setting. 
 meta-cognition and performance monitoring. Without support for this other 
strategies may be redundant as people with HAND may not be able to 
gain insight into the need for support.  
 
In 2014, the National Institutes of Health awarded a grant to a researcher linked 
to the CHARTER study to investigate metacognition based therapy for HAND in 
Methamphetamine users (Casaletto, 2014). Therapy involves teaching monitoring 
and self-regulation skills (see Sohlberg & Turkstra, 2011, for more detailed 
information) and results have yet to be published.  
 
4. Componential analysis and subscales are needed for other areas of 
functioning in HAND populations 
Category fluency, decision-making, planning, and now induction have been 
investigated for their underlying mechanisms in HAND. Murji and colleagues 
(2003) suggested maintenance of executive functions in HAND should be a top 
priority in order to limit subsequent cognitive decline and preserve quality of life. 
In order to identify treatment targets, other executive functions and their related 
tests should be analysed to quantify each skill contributing to ability or 
impairment. For example, inhibition could be investigated through qualitative 
analysis of tests such as the Stroop Colour-Word Test (Stroop, 1935) or Hayling 
Test (Burgess & Shallice, 1997). The Hayling Test already possesses a 
componential scoring system, categorising scores based on initiation speed, 
inhibition ability and thinking time. It is therefore a viable test for future use. 
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5. More focus is needed on the cultural validity of neuropsychological tests 
The relationship between primary language and the Word Context Test 
performance reiterates the need for language and culturally appropriate 
neuropsychological measures in order to avoid false-positives. It also suggests 
language fluency is not enough for a test to be considered applicable. 
 
As HIV continues to spread around the world, more studies will emerge calling for 
entire culture specific batteries and norms. In the short term, culture fair tests 
such as the Brixton, which does not need language knowledge, may be a more 
realistic goal (Manly et al., 2011). However, the notion of ‘culture fair’ testing has 
been challenged as some believe neuropsychological assessment is inherently 
culturally biased (e.g. Siedlecki et al., 2010). Clinicians may have more flexibility 
to work idiosyncratically with people, altering their assessments to include wider 
psychological formulation not solely based on neuropsychological testing. This 
may be more difficult to manage within research however, where data requires 
matched norms, samples and batteries.  
 
 
4.7 Critical review 
 
4.7.1 Sample  
Methodological rigour will have been affected by the sample size and limitations 
of the test materials utilized, meaning findings need to be interpreted with 
caution. A larger sample would have enhanced study validity and reliability, 
making results more generalisable to the wider population of people living with 
HAND. Recruitment and testing occurred within a limited time frame and the HIV-
positive population was drawn from a single group at Mildmay UK, restricting 
what was possible. Furthermore, a sample of people with ‘pure’ HAND was not 
achieved, as patients within the service presented with high levels of comorbidity, 
such as infections and a history of substance misuse, all of which have their own 
potential cognitive sequelae.  
 
Inclusion and exclusion criteria, and involvement of a non-study related 
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consultant to consider the impact of comorbidities on cognition aimed to improve 
selection of ‘suitable’ participants. Consultant inclusion was valuable due to the 
extensive knowledge brought in about each participant’s condition and also this 
field of research. Yet in hospital settings that are not the patient’s local medical 
centre, it is difficult to gain accurate histories, which suggests additional 
information may have been missed further affecting findings. This is particularly 
pertinent for those recently diagnosed with HIV yet appearing to have contracted 
the virus up to a decade ago, as little accurate information is available about 
disease progression. Therefore within these contexts, conclusions from this study 
are tentative at best.  
 
Regarding comorbidities, the diversity within the study reflects the population-
wide estimate of comorbidity prevalence in HAND (noted by Heaton et al., 2011). 
Additionally, exclusion of participants with comorbidities has been said to 
decrease ecological validity of research (Robertson et al., 2009) as it creates 
data not matching real-life situations. Excluding comorbidities may have 
decreased the ecological validity of the research, in addition to impeding 
recruitment. Furthermore, many comorbidities present within the sample are not 
well understood in terms of their link to cognition in HIV, post-treatment effects of 
toxoplasmosis for example. Further research would be needed to elucidate the 
effect of the comorbidities present within this study, and to pinpoint whether in 
fact these comorbidities obscure the findings or investigate the reality of the 
population in question. 
 
Age, education, ethnicity and language ability varied across both populations, 
although all met criteria for inclusion and were considered fluent in English. The 
literature documenting the effects of ill-matched demographic variables, or lack of 
cultural specificity of neuropsychological research, is extensive. The majority of 
HIV group participants were born outside of the UK, therefore there are 
implications for the validity of results as measures are biased towards western 
cultures. 
 
This was an exploratory study. In general, exploratory studies investigate whether 
specific phenomena occur under particular conditions in a given population and 
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can often incur similar limitations as those presented here. Larger scale 
secondary studies generally follow initial evidence that there is something to look 
for. Tentative findings in exploratory studies are therefore used as a base to 
guide subsequent research. 
 
 
4.7.2 Test materials and battery 
Assessing a cognitive domain or ability in a ‘pure’ way, through 
neuropsychological assessment, is hampered by the interplay between different 
abilities. For example, measures of memory necessitate language, attention and 
information processing. If one of these is affected, performance could 
erroneously suggest memory difficulties. The Brixton also cannot be said to be a 
pure measure, requiring attention and short term storage of previous trials shown. 
Careful interpretation of measures and comprehensive neuropsychological 
batteries can extrapolate certain factors arising in test performance, hence 
utilization of a full battery and multiple regression here. However, in general it can 
be difficult to state reliable conclusions about an individual ability from single 
tests.  
 
One strength of this study is that componential analysis in some way addresses 
the lack of specificity of the Brixton test, as it looks to identify mechanisms at play 
within participants’ performance. Furthermore, having taken the WCST scoring 
methodology (Heaton et al., 1993), and Burgess and Shallice’s (1996) comments 
into account, some of the themes could be considered reliable purely due to their 
documentation across multiple literatures. However, as previously mentioned, 
one researcher carried out the qualitative analysis, suggesting the need for future 
repetition of the study with think-aloud protocol and potentially more researchers. 
 
Sample size was small, but made smaller due to two people stopping the Brixton 
before completion. This has consequences for the findings but may also have 
methodological implications. The Brixton was the last test undertaken as it 
comprised part of the additional research battery. Therefore difficulties with 
completion may reflect test fatigue that was not addressed by breaks. The Brixton 
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was one of the tests with the longest duration, reasonably suggesting fatigue 
could be caused or exacerbated by this task. While all participants completed the 
Word Context Test, four HIV-positive patients gave the answer “don’t know” 
continuously, for up to the last five trials. Scores on this subtest could therefore 
also reflect exhaustion or decreased effort, rather than ability. An individual’s 
management of neuropsychological assessment provides information on 
cognitive ability. However, practical issues of testing unwell patients, such as test 
length, are well recognised. If this study were repeated the battery should be 
reassessed for necessity of each task, with a view to significantly decreasing test 
time. Otherwise, the measures of interest should be administered first to diminish 
the effects of fatigue.  
 
The findings within this study suggest that multi-faceted impairments can be seen 
in HAND based on one single test of induction, the Brixton. Without a functional 
assessment of peoples ADLs it is hard to see how Brixton findings impact 
people’s lived-experience, particularly as the test materials do not closely map 
onto daily activities and situations.  
 
Neuropsychological tests of executive function are often criticized for lack of 
verisimilitude (i.e. the level with which they resemble the real-life abilities they are 
supposed to test; Rai, 2014). However, Shallice (1988) argues that low 
verisimilitude is intentional, as most real-life activities become routine and 
possible to complete without cognitive engagement. Therefore 
neuropsychological tests generally present novel situations that necessitate on-
the-spot formulation and implementation of new strategies. This suggests that 
Brixton performance may therefore predict real-life functioning.  
 
Moreover, it could mean people with HAND may not display as impaired concept 
formation in routine areas of their life. As hospital settings can present a ‘novel’ 
environment, impairment documented here may overstate deficits experienced 
when at home or with known individuals. Conversely however, these tests were 
carried out in a quiet structured setting where participants are alerted to the 
requirements of the task at hand. In the ‘real-world’, multiple competing stimuli, 
such as noise and visuals, occur at the same time as people are expected to 
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complete tasks such as induction. If executive functioning is impaired in the way 
suggested within this study (where performance was seen to decrease as 
cognitive load increased), this would suggest impairment noted here may be an 
under-representation of real-life functional disruption. 
 
 
4.7.3 Personal reflections 
Research was carried out within an epistemology not commonly utilised in this 
field. There were times when it felt closer to positivist work as the quantitative 
methodology and neuropsychological battery mapped more closely onto this line 
of thought. However, inclusion of a qualitative element as well as reading linked 
to the socio-political aspects of HIV allowed more critical viewing of the test 
materials and literature gathered for the study. 
 
The work documented here was rewarding in terms of gaining skills in 
neuropsychological assessment, research and componential analysis. 
Simultaneously, challenges on multiple levels raised interesting issues. For 
example, before embarking on this study I continuously considered the 
constructed nature of emotional wellbeing, but was surprised at the extent to 
which a medical condition so firmly rooted within positivist traditions could be 
influenced by societal and cultural beliefs. HIV and transmission related stigma 
has been repeatedly shown to disable international, national and local abilities to 
implement effective preventative strategies, and decrease the likelihood that 
someone would test for and disclose an HIV-positive status.  
 
At the start of the project I had read articles and listened to talks that implicated 
inappropriate policy in the ongoing HIV pandemic, they also suggested that 
decreased fear of HIV due to available medication had led to decreased 
precautionary measures such as condom use (Pisani, 2010). Relating this to the 
Health Belief Model (Rosenstock, 1974) I queried whether increased information 
about the consequences of HIV could reinstate the necessity of prevention in 
people’s minds, as well as inform appropriate treatment. However, over the 
course of the work I have shifted towards a belief that research focused at the 
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individual can be redundant if not accompanied by social and political awareness, 
challenging the status quo at the national level. Therefore, while more research 
needs to be carried out to validate the findings of this study, my future focus 
would be to campaign against stigma, and for ongoing preventative strategies at 
a wider level.  
 
 
4.8 Future research 
 
Throughout the discussion further research ideas have been mentioned and the 
main points, and some final ideas are summarised here.   
 
1. Research to address shortcomings within this study: 
This study used a smaller sample size than was hoped for, furthermore, results 
were affected by variance within the group such as comorbidities and primary 
language. A larger version of this study with less variance would elucidate more 
generalisable findings. Inclusion of additional visuospatial measures of multiple 
trial concept formation would also improve the findings, identifying which 
components link more to the Brixton test than induction per se. Of upmost 
importance would be inclusion of a think-aloud protocol.  
 
2. Research to follow on from this study: 
It would be interesting to further this research by looking at the functional links 
between induction and ADLs in people with HAND. For research to be useful and 
ethical it should do more than inform professionals about a disease. If a 
functional link could be highlighted it may mean more to the people the research 
intends to serve, as well as providing further exploration of induction as 
measured outside of the clinic. 
 
Also, this study has shown the multiple aspects of performance underpinning 
induction in HAND. So far, category fluency, decision-making and planning have 
been explored componentially. Future research is needed to investigate other 
executive functions, including inhibition. 
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Further investigation into culturally acceptable assessment tools would create 
improved assessment, reflecting the diversity of PLWH. It would also clarify 
whether results within the literature pertain to HIV specifically, or to socio-political 
factors surrounding the disease and neuropsychological assessment. 
 
3. Research to adapt the Brixton: 
The Brixton would benefit from research leading to age-stratified norms for the 
younger population. Furthermore, it is necessary to create a validated 
componential system for the Brixton that can be utilised in clinical settings and in 
research. Repetition of componential analysis methods utilised in this study with 
multiple researchers would highlight reliably agreed upon criteria. Wider 
populations would need to be drawn from, particularly non-clinical samples, to 
identify generalisable performance styles. Larger scale multiple regression of 
components outlined in the new system could identify those important for 
performance on the test (Clark & Gardner, 1990).  
 
Brixton based componential analysis could be carried out in other cognitive 
impairments, including Parkinson’s disease (as Parkinson’s affects motor and 
cognition, similar to HIV) and frontal lobe damage or dementia (as this also 
affects cognition, especially executive functioning). This could be used to 
triangulate impairment styles, answering whether profiles emerge that directly link 
to disorder, or whether Brixton performance is always idiosyncratic (similar to 
performance seen in this study).  
 
Finally, some neuropsychological tests contain subtests to control for contributing 
factors. For example, the DKEFS Trail Making Test (Delis et al., 2001) has 
subtests to assess general speed, sequencing and switching separately. To 
improve componential analysis, a visuospatial short-term memory test could be 
built into the Brixton test, to account for perceptive and memory components 
affecting performance. This could be done using the same basic stimulus array 
used within the Brixton. For example, examinees could be shown a pattern, then 
asked to point to it on a separate page three seconds later.  
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4. General research:  
One conclusion from this study is the necessity of componential scoring systems 
to understand the complexity of individuals’ performance. Scales need to be 
created for tests not already using them (e.g. WAIS-III and WAIS IV tests such as 
Similarities and Matrices Reasoning) for use across all, not solely HIV-related, 
clinical and patient settings. 
 
 
4.9 Conclusion 
 
This study highlights the complexity of executive functions within a non-clinical 
and clinical population, which is often ignored within neuropsychological 
measures since basic test scores are often taken at face value. Through an 
attempt at addressing this, it became clear that like other cognitive domains 
(except visuospatial domains), induction is impaired in HAND. Multiple factors are 
responsible for this rather than rule detection alone. This appears to be the first 
study documenting mechanisms underpinning induction within this population 
and suggests that rule detection at its simplest may be spared. However, 
difficulties occur if cognitive demand is increased. Information processing, lapses 
in attention or working memory, and other mechanisms (either impulsivity, 
problem solving deficits or another unknown variable) appear to comprise initial 
deficits in induction. Secondary deficits affecting induction arise as the disease 
progresses or performance on the Brixton decreases, they include cognitive 
rigidity and monitoring difficulties. However, performance was not exclusively 
consistent. 
 
Clinically, this implies that wider testing is required, including componential 
analysis. This is important not only to test these findings but also to document 
individual idiosyncrasies that affect the type of treatment most appropriate for 
each person presenting with difficulties linked to HAND. 
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6 APPENDIXES 
APPENDIX A. Information on HAND, comorbidities and risk 
 
Hepatitis C 
Hepatitis C viral infection (HCV) is a blood-borne virus diagnosed in 55-90% of 
HIV-positive intravenous drug users (IDUs). Alone HCV replicates in the CNS 
leading to neuropsychological consequences. When co-occurring with HIV 
infection, HCV is thought to have additive effects on cognitive impairment (e.g. 
Giesbrecht et al., 2014) leading to further impaired learning, speed, recall ability 
and problem solving (Cherner et al., 2005). Furthermore, in a study looking at the 
relationship between HIV, hepatitis C, substance use and HIV disease measures 
(e.g. current and nadir CD4, HIV RNA, duration of infection), hepatitis C was the 
most consistent predictor of poor cognitive performance (Devlin et al., 2012). 
However, one study found HCV did not contribute to neurocognitive impairment, 
when HCV had no associated liver damage (Clifford et al., 2015). As HCV is 
usually passed through IDU, substance use will also affect the findings of 
research carried out on HCV and HIV. 
  
HAND and substance use 
Drugs, both legal and illicit, are known to have significant deleterious effects on 
neurochemistry. Therefore it is not unexpected that poorer neurocognitive 
outcomes have been found in PLWH who use any of the following: alcohol, 
methamphetamine, opioids, Ecstasy/MDMA and other ‘club’ drugs (Kennedy & 
Zerbo, 2014). 
  
An example of this is alcohol, which affects cerebellar, prefrontal structures and 
the limbic system leading to cognitive impairment over time (Sullivan & 
Pfefferbaum, 2014). Together HIV and alcoholism have been shown to have 
synergistic effects. Leading to increased severity of HIV symptoms (Heinz, 
Fogler, Newcomb, Trafton & Bonn-Miller, 2014) and impairment in reaction times, 
verbal reasoning, visuospatial perception and episodic memory, causing 
impairments far greater than seen in individuals with either HIV infection or 
alcoholism alone (Fama et al., 2011). 
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It must be noted that drug use is often accompanied by lower socio-economic 
status, nutrition, education levels, and higher rates of head injury, other 
neurological compromise and psychiatric disorders (Durvasula & Hinkin, 2006). 
Each of which confounds research carried out in the area. It would therefore be 
hard to extrapolate the effect of each of these variables. 
 
Mental health  
A higher prevalence of mental health diagnoses is found in PLWH than in the 
general population. For example, estimates suggest 4-23% of PLWH (Cournos & 
McKinnon, 1997) also live with a diagnosis of schizophrenia (compared to 0.87 in 
the general population; Perälä et al., 2007), and that PLWH are two to three 
times more likely to have a diagnosis of depression (Tucker, Buram, Sherbourne, 
Kung & Gifford, 2003). 
 
A reciprocal relationship has been suggested to exist between HIV and 
diagnosed mental health problems. Specifically, poor mental health has been 
linked to increased risk of transmission and transmission linked to decreasing 
psychological wellbeing. Furthermore, disruption of cART adherence has been 
linked to poor mental health, which increases risk of further illness and mortality 
(Anand, Springer, Copenhaver & Altice, 2010). 
  
As with all areas of HIV another study noted the inverse. The study followed HIV-
negative people with and without diagnosed mental health conditions over a two 
year period, finding that people with a serious mental health diagnosis were 23% 
less likely to become HIV-positive than those with good mental health (Prince, 
Walkup, Akincigil, Amin & Crystal, 2012). However, this study only included what 
it determined to be a serious condition (i.e. bipolar disorder or schizophrenia), 
and placed people with anxiety and depression in a different group. 
 
Suggestions exist that different mental health diagnoses have cognitive sequelae. 
Schizophrenia is thought to impair executive functioning (Angelino & Treisman, 
2008) while depression has been linked to deficits in motivation, verbal memory, 
executive functioning and motor performance (Castellon et al., 2006). 
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Additionally, anxiety is thought to affect speed, memory and switching ability 
(Beaudreau & O’Hara, 2009). Therefore, it may be expected that HIV and mental 
health could have an additive effect. However, extrapolating the effect of either 
would be difficult. 
 
Little research exists investigating mental health and HAND. Depression and 
anxiety has been linked to higher rates of HAND in men (Micali, Zirilli, & Abbate, 
2011). However, the CHARTER study found no relationship between depressed 
mood and neuropsychological HIV sequelae (Heaton et al., 2015). No specific 
research looking at HAND and schizophrenia has been carried out to the author’s 
knowledge.  
 
The directionality of the effects, when found at all in the literature, is not clear. 
Furthermore, the validity and reliability of the mental health constructs 
(schizophrenia, depression and anxiety) have been questioned (e.g. Rapley, 
Moncrieff & Dillon, 2011) putting the reliability of the mental health and HIV 
research into question. In line with previous comments regarding socio-
demographic aspects people with mental health diagnoses experience stigma 
and are positioned at lower levels of society (Wilkinson & Pickett, 2010) 
suggesting these factors may also be at play. 
 
Other 
Other factors influencing HAND include genetic factors. For example, The APOE 
ɛ4 allele has been associated with HAD, but links to mild and moderate HAND 
are unclear (Kallianpur & Levine, 2014). Inactive lifestyles have also been 
postulated to link to HAND. The directionality of this claim is unclear as, while it is 
possible that activity protects against decline, it is also possible that better/worse 
neurocognitive functioning instead leads people to be more/less inclined to be 
active (Fazeli et al., 2014). 
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APPENDIX B. Example of Brixton set 1 (rule 1): circle moves forward 1 position3 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                            
3 Shown across three different stimulus arrays (each rectangle represents a new array/page). 
 
1
1 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
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APPENDIX C. Example of Brixton set 2 (rule 2): circle moves back 1 position4 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                            
4 Shown across three different stimulus arrays (each rectangle represents a new array/page). 
 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
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APPENDIX D. Example of Brixton set 3 (rule 3): circle alternates between 10 & 55 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                            
5 Shown across three different stimulus arrays (each rectangle represents a new array/page). 
 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
     6       7   8             9          10 
     1     2   3             4            5 
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APPENDIX E. Example of Brixton set 4 (repeat rule 1): circle moves forward 16 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                            
6 Shown across three different stimulus arrays (each rectangle represents a new array/page). 
 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
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APPENDIX F. Example of Brixton set 5 (repeat rule 2): circle moves back 17 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
                                            
7 Shown across three different stimulus arrays (each rectangle represents a new array/page). 
 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
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APPENDIX G. Example of Brixton set 6 (repeat rule 1): circle moves forward 18 
 
 
  
                                            
8 Shown across three different stimulus arrays (each rectangle represents a new array/page). 
 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
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APPENDIX H. Example of Brixton set 7 (rule 4): circle alternates between 10 & 49 
 
 
  
                                            
9 Shown across three different stimulus arrays (each rectangle represents a new array/page). 
 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
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APPENDIX I. Example of Brixton set 8 (rule 5): circle stays in position 910) 
 
 
  
                                            
10 Shown across three different stimulus arrays (each rectangle represents a new array/page). 
 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
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APPENDIX J. Example of Brixton set 9 (rule 6): circle alternates between 8 & 911) 
 
 
  
                                            
11 Shown across three different stimulus arrays (each rectangle represents a new array/page). 
 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
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APPENDIX K. UEL Ethical approval and checklist 
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ETHICAL PRACTICE CHECKLIST (Professional Doctorates) 
 
 
SUPERVISOR:  Matthew Jones Chesters  ASSESSOR: Davide 
Rivolta 
 
STUDENT: Sophie Inchley Mort  DATE (sent to assessor): 01/07/2014 
 
Proposed research topic: Induction and HIV-associated Neurocognitive 
Disorders 
 
Course: Professional Doctorate in Clinical Psychology 
 
 
1.   Will free and informed consent of participants be obtained?  YES   
 
2.   If there is any deception is it justified?     N/A  
           
3.   Will information obtained remain confidential?     YES  
      
4.   Will participants be made aware of their right to withdraw at any time? YES  
 
5.   Will participants be adequately debriefed?    YES   
      
6.   If this study involves observation does it respect participants’ privacy? NA 
  
7.   If the proposal involves participants whose free and informed 
      consent may be in question (e.g. for reasons of age, mental or 
      emotional incapacity), are they treated ethically?   NA  
   
8.   Is procedure that might cause distress to participants ethical?  NA 
 
9.   If there are inducements to take part in the project is this ethical? NA  
   
10. If there are any other ethical issues involved, are they a problem? NA  
 
APPROVED   
  
YES   
      
 
MINOR CONDITIONS:   
 
 
REASONS FOR NON APPROVAL:  
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Assessor initials: DR    Date:  01 July 2014 
 
 
RESEARCHER RISK ASSESSMENT CHECKLIST (BSc/MSc/MA) 
 
SUPERVISOR:  Matthew Jones Chesters  ASSESSOR: Davide 
Rivolta 
 
STUDENT: Sophie Inchley Mort   DATE (sent to assessor): 
01/07/2014 
 
Proposed research topic: Induction and HIV-associated Neurocognitive 
Disorders 
 
Course: Professional Doctorate in Clinical Psychology 
 
Would the proposed project expose the researcher to any of the following kinds 
of hazard? 
 
1 Emotional   NO 
 
2. Physical   NO 
 
3. Other    NO 
 (e.g. health & safety issues) 
 
If you’ve answered YES to any of the above please estimate the chance of the 
researcher being harmed as:      HIGH / MED / LOW  
 
APPROVED   
 
YES   
      
 
MINOR CONDITIONS:   
 
REASONS FOR NON APPROVAL:  
 
Assessor initials:  DR  Date:  1st July 2014 
 
 
 
 
For the attention of the assessor: Please return the completed checklists by e-
mail to ethics.applications@uel.ac.uk within 1 week. 
  
 151 
 
APPENDIX L. Consent form (both groups) 
 
 
CONSENT FORM 
UNIVERSITY OF EAST LONDON 
CONSENT FORM 
Title of Project: Componential analysis of induction and executive function in HIV associate 
neurocognitive disorders 
Name of Researcher:  Sophie Inchley-Mort 
Please initial all 
boxes  
1. I confirm that I have read and understand the information sheet for the above study.  
I have had the opportunity to consider the information, ask questions and have had 
these answered satisfactorily. 
   
2. I understand that my participation is voluntary and that I am free to withdraw at any 
time without giving any reason, without my medical care or legal rights being 
affected.  
 
3. I understand that all information collected in this study will remain strictly 
confidential. Only the researcher(s) involved in the study will have access to 
identifying data. It has been explained to me what will happen once the research 
study has been completed. 
 
4. I agree to take part in the above study.    
 
            
Name of Participant   Date    Signature 
                                
            
Name of person taking consent  Date    Signature   
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APPENDIX M. Participant information (HIV Group) 
 
 
PARTICIPANT INVITATION LETTER 
UNIVERSITY OF EAST LONDON 
INFORMATION SHEET 
Title of Project: Componential analysis of induction and executive function in HIV associate 
neurocognitive disorders 
Name of Researcher:  Sophie Inchley-Mort 
Who am I? 
I am Sophie and I am a clinical psychology trainee at the University of East 
London. My email address is u1235022@uel.ac.uk 
What is this about? 
I am doing a study that looks at the effect of HIV infection on people’s ability to 
think, learn and follow new information. Finding out about this will improve our 
understanding of the impact of HIV on the brain and on daily living skills. It will 
also help us know how to give better care, and make better interventions for 
people with HIV in the future.  
 
What does the study involve? 
 If you decide that you would like to be involved you will be invited to complete a 
set of psychological tests which look at different types of abilities, such as 
attention, problem solving and memory. Some of the tests involve verbal 
questions and responses and others will be pen and paper exercises. In total, the 
tests will last approximately 90 minutes and you will be able to have a break in 
the middle. If you change your mind you can withdraw from the study at any time. 
If you do, any information that you have given will not be used.  
 
What happens to the information we collect? 
Any information that you give to us for the study will be kept confidentially. All 
names and identifiable information will be removed and kept separately from the 
information that the service holds about you.  
What happens to the results of the study? 
The results that come from this research will be written up in a doctoral thesis 
that will be submitted to the University of East London. The write up may also be 
published in an academic journal in the future to help increase understanding of 
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HIV and its effect on the brain. No identifiable information of any participant will 
be included in either report.  
  
What will happen afterwards? 
Before, during, and after the assessment session I will be there to answer any 
questions or concerns you have about the study. 
  
What should I do if I have any questions now? 
If you have any questions about the study you can contact me on: 
Email address: u1235022@uel.ac.uk 
Or  
Dr Matthew Jones Chesters (Clinical Psychologist/tutor at the University of East 
London) on: 
Email address: m.h.jones-chesters@uel.ac.uk 
 
Thank you  
Sophie Inchley-Mort 
Trainee Clinical Psychologist 
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APPENDIX N. Participant information (Control group) 
 
 
PARTICIPANT INVITATION LETTER 
UNIVERSITY OF EAST LONDON 
INFORMATION SHEET 
Title of Project: Componential analysis of induction and executive function in HIV associate 
neurocognitive disorders 
Name of Researcher:  Sophie Inchley-Mort 
Who am I? 
I am Sophie and I am a clinical psychology trainee at the University of East 
London. My email address is u1235022@uel.ac.uk 
What is this about? 
I am doing a study that looks at the effect of HIV infection on people’s ability to 
think, learn and follow new information. Finding out about this will improve our 
understanding of the impact of HIV on the brain and on daily living skills. It will 
also help us know how to give better care, and make better interventions for 
people with HIV in the future. I am also collecting information from people without 
HIV infection so that I can compare the results between the two groups and see 
what changes following HIV infection.  
 
What does the study involve? 
If you decide that you would like to be involved you will be invited to complete a 
couple of psychological tests which look at different types of abilities, such as 
attention, rule detection and memory. Some of the tests involve verbal questions 
and responses, and others will be pen and paper exercises. In total, the tests will 
last approximately 15-20 minutes. If you change your mind you can withdraw 
from the study at any time. If you do, any information that you have given will not 
be used.  
 
What happens to the information we collect? 
Any information that you give to us for the study will be kept confidentially. All 
names and identifiable information will be removed and kept separately from the 
information that the service holds about you.  
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What happens to the results of the study? 
The results that come from this research will be written up in a doctoral thesis 
that will be submitted to the University of East London. The write up may also be 
published in an academic journal in the future to help increase understanding of 
HIV and its effect on the brain. No identifiable information of any participant will 
be included in either report.  
  
What will happen afterwards? 
Before, during, and after the assessment session I will be there to answer any 
questions or concerns you have about the study. 
  
What should I do if I have any questions now? 
If you have any questions about the study you can contact me on: 
Email address: u1235022@uel.ac.uk 
Or  
Dr Matthew Jones Chesters (Clinical Psychologist/tutor at the University of East 
London) on: 
Email address: m.h.jones-chesters@uel.ac.uk 
 
Thank you  
Sophie Inchley-Mort 
Trainee Clinical Psychologist 
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APPENDIX O. Scaled scores and subjective labels (adapted from Slick, 2006) 
 
 
Scaled Score Range 
19 
Very Superior 
 
18 
17 
16 
15 Superior 
14 
13 High Average 
12 
11 
Average 10 
9 
8 Low Average 
7 
6 Below Normal 
5 
4 
Impaired 3 
2 
1 
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APPENDIX P. Table of Participant Characteristics (HIV Group)12 
 
No. Age Sex Ethnicity  Is 
Primary 
language 
English? 
Educ
ation 
(year
s) 
Year 
Diagnosed 
(nadir 
CD4) 
CD4 Viral Load 
1 38 F Kenyan Yes 12 2014  
(130) 
24 450 
2 46 M White 
British  
Yes 16 2007  
(308) 
310 122 
3 50 F Ethiopian  No 14 1997  
(100) 
340 1200 
4 58 M White 
British 
Yes 21 2013  
(140) 
239 Unknown 
5 65 M Ghanaian No 14 2014 
(200) 
200 133000 
6 49 M Nigerian  No 14 2012  
(50) 
50 97000 
7 65 M White 
British  
Yes 15 1998  
(138) 
200 <40 
8 49 M Ugandan No 12 1993 
(Unknown) 
194 167655 
9 56 M Ugandan Yes 18 2007  
(17) 
178 101 
10 40 M Portuguese Yes 13 2001 
(Unknown) 
36 Unknown 
11 61 M White 
British  
Yes 11 2014  
(47) 
92 97000 
12 47 F Ethiopian No 17 2004  
(37) 
400 1300 
13 44 M White 
British  
Yes 6 1990  
(60) 
60 Unknown 
 
  
                                            
12 Comorbidities for each participant are presented in table 14 
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APPENDIX Q. Table of Participant Characteristics (Control Group) 
 
No. Age Sex Ethnicity & 
Country of 
Birth 
Is 
Primary 
language 
English? 
Education 
(years) 
Additional 
Information 
14 48 M White 
British 
Yes 15 None 
15 54 M Indian No 8 None 
16 43 M White 
British 
Yes 14 None 
17 41 F White 
British 
Yes 18 None 
18 55 F White 
British 
Yes 15 Thyroid problem 
19 47 M South 
African 
Yes 15 None 
20 65 M Portuguese No 17 Pain condition 
21 40 F Indian No 17 Diabetes 
22 65 M White 
British 
Yes 10 None 
23 36 M Black 
British 
Yes 17 None 
24 64 M White 
British 
Yes 12 None 
25 60 F White 
British 
Yes 14 None 
26 32 M White 
British 
Yes 12 None 
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APPENDIX R: Example of the Brixton Spatial Anticipation Test scoring form 
 
Figure 8. Scoring section of the Brixton (from Burgess & Shallice, 1997) 
Item Ans Resp Score  Item Ans 
Res
p 
Score  Item Ans Resp 
Sco
re 
1  -     21 8    41 4   
2 3    22 9    42 9   
3 4    23 10    43 9   
4 5    24 1    44 9   
5 6    25 2    45 9   
6 7    26 3    46 9   
7 4    27 10    47 9   
8 3    28 9    48 9   
9 2    29 8    49 9   
10 1    30 1    50 8   
              
11 10    31 2    51 9   
12 9    32 3    52 8   
13 10    33 4    53 9   
14 5    34 5    54 8   
15 10    35 4    55 9   
16 5    36 10        
17 10    37 4        
18 5    38 10    TOTAL 
ERRORS 
 
19 10    39 4    
20 7    40 10        
 
 
Information about columns on the score sheet 
Item column shows the trial number  
Ans column is the correct answer needed to score correctly on the trial 
Resp column is where the actual answer of the participant is inserted 
Score column is where the answer is marked correct or incorrect.   
 
 
Information about trials and sets13: 
Set 1 = trials 1-6     Set 6 = trials 30-34 
Set 2 = trials 7-13     Set 7 = trials 35-41 
Set 3 = trials 14- 19    Set 8 = trials 42- 49 
Set 4 = trials 20- 26    Set 9 = trials 50-55 
Set 5 = trials 27-29  
                                            
13 Rules used in each set are described in Appendixes B – J. 
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APPENDIX S: Example of marking using the novel scale on the Brixton Spatial 
Anticipation Test 
 
Figure 9. Completed Brixton score sheet (answers are hypothetical)  
Item Ans Resp Score  Item Ans 
Res
p 
Score  Item Ans Resp 
Sco
re 
1  -  2 -  21 8 8   41 4 4 x 
2 3 3   22 9 9   42 9 8 x 
3 4 4   23 10 10   43 9 10 x 
4 5 5   24 1 5 x  44 9 9  
5 6 6   25 2 2 x  45 9 4 x 
6 7 7   26 3 3   46 9 2 x 
7 4 8 x  27 10 2 x  47 9 5 x 
8 3 3   28 9 10 x  48 9 5 x 
9 2 2   29 8 10 x  49 9 1 x 
10 1 1   30 1 1   50 8 8  
              
11 10 6 x  31 2 2   51 9 9  
12 9 9   32 3 3   52 8 8  
13 10 10   33 4 3 x  53 9 9  
14 5 5   34 5 4 x  54 8 8  
15 10 10   35 4 4   55 9 9  
16 5 5   36 10 10       
17 10 10   37 4 4       
18 5 5   38 10 10   TOTAL 
ERRORS 
19 
19 10 10   39 4 4   
20 7 1 x  40 10 5 x      
 
Overall scores: 
Sets gained = set 1, 2, 3, 4, 6, 7, 9 (7 sets out of 9)  
Rules gained = 1, 2, 3, 4, 6 (5 rules out of 6) 
Trials to acquire sets= 13    
Sets lost = 2, 4, 7 (3 lost) 
          
 
Error Key:           Count 
Green = set-loss due to 1-10 shift (also in this error due to 1-10 shift)    1 
Pink = set-loss, reverting to 10-5 rule         1 
Purple = set-loss, anticipation (participant verbalised)      1 
Red = regained set           2 
Grey = response capture          2 
Pale blue = error type, no observable strategy       4 
Dark green = perseverate with previous answer       3 
Black = perseverate with previous rule        2 
Yellow = monitoring error, did not realise rule change      1 
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APPENDIX T. Example of the 1-10 shift  
 
When the circle reaches position 1 during set 2 (circle moves backwards by 1) it 
then moves to position 10 (see below). However in some cases, people who had 
already acquired the set would state that the circle was going to move to position 
6 or another position which did not follow the set 2 rule. This also happened when 
the circle was in position 10 and was meant to move to position 1.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
     1     2   3             4            5 
     6       7   8             9          10 
     1     2   3             4            5 
     6       7   8             9          10 
